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The rapid technological developments of the past decade and the changes in echocardiographic practice
brought about by these developments have resulted in the need for updated recommendations to the previ-
ously published guidelines for cardiac chamber quantification, which was the goal of the joint writing group
assembled by the American Society of Echocardiography and the European Association of Cardiovascular
Imaging. This document provides updated normal values for all four cardiac chambers, including three-
dimensional echocardiography and myocardial deformation, when possible, on the basis of considerably
larger numbers of normal subjects, compiled from multiple databases. In addition, this document attempts
to eliminate several minor discrepancies that existed between previously published guidelines. (J Am Soc
Echocardiogr 2015;28:1-39.)
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Abbreviations
AP = Anteroposterior
ASE = American Society of
Echocardiography
BSA = Body surface area
CMR = Cardiac magnetic
resonance
DTI = Doppler tissue imaging
EACVI = European
Association of Cardiovascular
Imaging
EDV = End-diastolic volume
EF = Ejection fraction
ESV = End-systolic volume
FAC = Fractional area change
GLS = Global longitudinal
strain
I-I = Inner edge–to–inner edge
IVC = Inferior vena cava
LA = Left atrial
L-L = Leading edge–to–
leading edge
LV = Left ventricular
MDCT = Multidetector
computed tomography
PW = Pulsed-wave
RA = Right atrial
RIMP = Right ventricular index
of myocardial performance
RV = Right ventricular
RWT = Relative wall thickness
STE = Speckle-tracking
echocardiography
TAPSE = Tricuspid annular
plane systolic excursion
TAVI = Transcatheter aortic
valve implantation
TAVR = Transcatheter aortic
valve replacement
TEE = Transesophageal
echocardiography
3D = Three-dimensional
3DE = Three-dimensional
echocardiography
TTE = Transthoracic
echocardiography
2D = Two-dimensional
2DE = Two-dimensional
echocardiography
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stone of cardiac imaging, with echocardiography being the most
commonly used noninvasive modality because of its unique ability
to provide real-time images of the beating heart, combined with its
availability and portability. Standardization of the methodology
used to quantify cardiac chambers is maintained by creating and
disseminating official recommendations, which when followed by
practitioners provides uniformity and facilitates communication.
Recommendations for echocardiographic chamber quantification
were last published in 2005 by the American Society of
Echocardiography (ASE) and the European Association of
Echocardiography (renamed the European Association of
Cardiovascular Imaging [EACVI]).1,2
Since then, echocardiographic technology has continued
evolving, with two major developments being real-time three-
dimensional (3D) echocardiography (3DE) and myocardial defor-
mation imaging. The goal of this document is to provide an update
to the previously published guidelines, as well as recommendations
and reference values, while eliminating the minor discrepancies that
existed between previous guidelines. The normal values in this up-
date include 3DE and myocardial deformation, when possible.
Importantly, compared with the previous guidelines, this update is
based on considerably larger numbers of normal subjects, compiled
from multiple databases, to improve the reliability of the reference
values.
Although most issues covered in this document reflect a broad
consensus among the members of the writing group, one important
issue the group debated was partition values for severity of abnormal-
ities. Most often, in addition to describing a parameter as normal or
abnormal (reference values), clinical echocardiographers qualify the
degree of abnormality with terms such as mildly, moderately, and
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deviate from normal. In addition to providing normative data, it
would be beneficial to standardize cutoffs for severity of abnormality
for all parameters across echocardiography laboratories, such that the
term moderately abnormal, for example, would have the same mean-
ing universally. However, different approaches may be used for deter-
mining cutoff values for the different degrees of abnormality, all of
which have significant limitations.
The first approach would be to empirically define cutoffs for
mild, moderate, and severe abnormalities on the basis of SDs above
or below the reference limit derived from a group of healthy people.
The advantage of this method is that these data readily exist for
most echocardiographic parameters. However, this approach is
fundamentally flawed. First, not all echocardiographic parameters
are normally distributed (or Gaussian), even in a normal population.
Second, even if a particular parameter is normally distributed in
normal subjects, most echocardiographic parameters, when
measured in the general population, have a significant asymmetric
distribution in one direction (abnormally large for size or abnormally
low for function parameters). An alternative method would be to
define abnormalities on the basis of percentile values (e.g., 95th,
99th) of measurements derived from a population that includes
both healthy people and those with disease. Although these data
would still not be normally distributed, they would account for
the asymmetric distribution and the range of abnormality present
within the general population. The major limitation of this approach
is that such population data sets simply do not exist for most echo-
cardiographic variables.
Ideally, an approach that predicts outcomes or prognosis would be
preferred. That is, defining a variable as moderately deviated from
normal would imply that there is a moderate risk for a particular
adverse outcome for a patient. Although sufficient data linking risk
and cardiac chamber sizes exist for several parameters (e.g., left ven-
tricular [LV] size and ejection fraction [EF], left atrial [LA] volume),
outcomes data are lacking for many other parameters.
Unfortunately, this approach also has limitations. The first obstacle
is how to best define risk. The cutoffs suggested for the same param-
eter vary broadly for different risks in different patient populations
and disease states.
Last, cutoff values may be determined by experience-based
consensus of expert opinions. An extensive debate arose among
the members of the writing group, some of whom felt that
providing partition values on the basis of this scientifically less-
than-rigorous approach would be a disservice to the echocardiog-
raphy community and that a disease-specific approach might be
required to achieve meaningful clinical categorization of the
severity of abnormality. Others felt that such cutoffs would pro-
vide a uniform reference for echocardiographic reporting, which
would be easier to interpret by referring clinicians. The compro-
mise was to provide experience-based partition values only for
LV EF and LA volume, while suggested partition values for addi-
tional parameters of LV size and mass are listed in the
Appendix. All partition values should interpreted with caution
in this perspective.
For parameters other than LV size, function, and mass as well as
LA volume, only the mean value and the SD of gender-, age-, and
body surface area (BSA)–normalized cutoffs or upper and lower
limits are reported in the appropriate sections of this document.
For these parameters, measurements exceeding 61.96 SDs (i.e.,
the 95% confidence interval) should be classified as abnormal.
Any description of the degree of deviation from normality in theechocardiographic report should remain at the discretion of the in-
dividual laboratory, and the writing group does not recommend spe-
cific partition values.
Quantification using transesophageal echocardiography (TEE)
has advantages and disadvantages compared with transthoracic
echocardiography (TTE). Although visualization of many cardiac
structures is improved with TEE, some differences in measure-
ments have been found between TEE and TTE, particularly for
chamber dimensions and thickness. These differences are primarily
attributable to the inability to obtain from the transesophageal
approach the standardized imaging planes and views used when
quantifying chamber dimensions transthoracically. It is the recom-
mendation of this writing group that the same range of normal
values for LV and right ventricular (RV) chamber dimensions and
volumes apply for both TEE and TTE. For details on specific views
for optimal measurements, please refer to the recently published
TEE guidelines.3
All measurements described in this document should be per-
formed on more than one cardiac cycle to account for interbeat
variability. The committee suggests the average of three beats for
patients in normal sinus rhythm and a minimum of five beats in
patients with atrial fibrillation. Because the committee acknowl-
edges that the implementation of this recommendation is time
consuming, the use of representative beats is acceptable in the clin-
ical setting.I. THE LEFT VENTRICLE1. Measurement of LV Size
The most commonly used parameters to describe LV cavity size
include linear internal dimensions and volumes. Measurements are
commonly reported for end-diastole and end-systole, which are
then used to derive parameters of global LV function. To allow com-
parison among individuals with different body sizes, chamber mea-
surements should be reported indexed to BSA.
1.1. LinearMeasurements. It is recommended that linear internal
measurements of the left ventricle and its walls be performed in the
parasternal long-axis view. Values should be carefully obtained
perpendicular to the LV long axis and measured at or immediately
below the level of the mitral valve leaflet tips. In this regard, the elec-
tronic calipers should be positioned on the interface between the
myocardial wall and cavity and the interface between the wall and
the pericardium. Internal dimensions can be obtained with a two-
dimensional (2D) echocardiography (2DE)–guided M-mode
approach, although linear measurements obtained from 2D echocar-
diographic images are preferred to avoid oblique sections of the
ventricle (Table 1).
1.2. Volumetric Measurements. LV volumes are measured using
2DE or 3DE. Volume calculations derived from linear measurements
may be inaccurate, because they rely on the assumption of a fixed
geometric LV shape such as a prolate ellipsoid, which does not apply
in a variety of cardiac pathologies. Accordingly, the Teichholz and
Quinones methods for calculating LV volumes from LV linear dimen-
sions are no longer recommended for clinical use.
Volumetric measurements are usually based on tracings of the
interface between the compacted myocardium and the LV cavity.
Table 1 Recommendations for the echocardiographic assessment of LV size and function
Parameter and method Technique Advantages Limitations
Internal linear
dimensions.
Linear internal
measurements of the LV
should be acquired in the
parasternal long-axis
view carefully obtained
perpendicular to the LV
long axis, and measured
at the level of the mitral
valve leaflet tips.
Electronic calipers
should be positioned on
the interface between
myocardial wall and
cavity and the interface
between wall and
pericardium (orange
arrows).
M-mode tracing
2D-guided linear measurements
 Reproducible
 High temporal
resolution
 Wealth of published
data
 Facilitates orientation
perpendicular to the
ventricular long axis
 Beam orientation
frequently off axis
 Single dimension, i.e.,
representative only in
normally shaped
ventricles
 Lower frame rates
than M-mode
 Single dimension, i.e.,
representative only in
normally shaped
ventricles
Volumes.
Volume measurements
are usually based on
tracings of the blood-
tissue interface in the
apical four- and two-
chamber views. At the
mitral valve level, the
contour is closed by
connecting the two
opposite sections of the
mitral ring with a straight
line. LV length is defined
as the distance between
the middle of this line
and the most distant
point of the LV contour.
Biplane disk summation  Corrects for shape
distortions
 Less geometrical
assumptions
compared with linear
dimensions
 Apex frequently
foreshortened
 Endocardial dropout
 Blind to shape distor-
tions not visualized in
the apical two- and
four-chamber planes
Area-length
 Partial correction for
shape distortion
 Apex frequently
foreshortened
 Heavily based on
geometrical
assumptions
 Limited published
data on normal
population
(Continued )
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Table 1 (Continued )
Parameter and method Technique Advantages Limitations
Endocardial border enhancement
3D data sets
 Helpful in patients with
suboptimal acoustic
window
 Provides volumes that
are closer to those
measuredwith cardiac
magnetic resonance
 No geometrical
assumption
 Unaffected by
foreshortening
 More accurate and
reproducible
compared to other
imaging modalities
 Same limitations as
the above non-
contrast 2D
techniques
 Acoustic shadowing in
LV basal segments
with excess contrast
 Lower temporal
resolution
 Less published data
on normal values
 Image quality
dependent
Global Longitudinal
Strain.
Peak value of 2D
longitudinal speckle
tracking derived strain
(%).
 Angle independent
 Established
prognostic value
 Vendor dependent
2D, two-dimensional; 3D, three-dimensional;A2C, apical 2-chamber view;A4C, apical 4-chamber view; EDV, end-diastolic volume; ESV, end-sys-
tolic volume; LV, left ventricular.
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opposite sections of the mitral ring with a straight line. LV length is
defined as the distance between the bisector of this line and the apical
point of the LV contour, which is most distant to it. The use of the
longer LV length between the apical two- and four-chamber views
is recommended.
LV volumes should be measured from the apical four- and
two-chamber views. Two-dimensional echocardiographic image
acquisition should aim to maximize LV areas, while avoiding fore-
shortening of the left ventricle, which results in volume underes-
timation. Acquiring LV views at a reduced depth to focus on
the LV cavity will reduce the likelihood of foreshortening andminimize errors in endocardial border tracings (Table 1).
Because the issue of foreshortening is less relevant in 3D data
sets, 3D image acquisition should focus primarily on including
the entire left ventricle within the pyramidal data set. To ensure
reasonably accurate identification of end-systole, the temporal res-
olution of 3D imaging should be maximized without compro-
mising spatial resolution.
Contrast agents should be used when needed to improve endocar-
dial delineation when two or more contiguous LV endocardial
segments are poorly visualized in apical views, as per published guide-
lines.4 Contrast-enhanced images may provide larger volumes than
unenhanced images that are closer to those obtained with cardiac
6 Lang et al Journal of the American Society of Echocardiography
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should be taken to avoid acoustic shadowing, which may occur in
LV basal segments in the presence of high concentrations of contrast.
Normal reference values for LV volumes with contrast enhancement
are not well established.
The most commonly used method for 2D echocardiographic
volume calculations is the biplane method of disks summation
(modified Simpson’s rule), which is the recommended 2D echocar-
diographic method by consensus of this committee (Table 1). An
alternative method to calculate LV volumes when apical endocardial
definition precludes accurate tracing is the area-length method, in
which the LV is assumed to be bullet shaped. The mid-LV cross-
sectional area is computed by planimetry in the parasternal short-
axis view and the length of the ventricle taken from the midpoint
of the annular plane to the apex in the apical four-chamber view
(Table 1). The shortcoming of this method is that the bullet-shape
assumption does not always hold true. One of the advantages of
3D echocardiographic volume measurements is that they do not
rely on geometric assumptions. In patients with good image quality,
3D echocardiographic measurements are accurate and reproducible
and should therefore be used when available and feasible.6 The ad-
vantages and disadvantages of the various methods are summarized
in Table 1.
1.3. Normal Reference Values for 2DE. Data were extracted
from seven databases, including Asklepios (year 0 and year 10),7
Flemengho,8 CARDIA5 and CARDIA25,9 Padua 3D Echo
Normal,10 and the Normal Reference Ranges for
Echocardiography study,11,12 to obtain reference values in normal
subjects for the left ventricle and the left atrium (see section 10).
All data were obtained without the use of contrast agents. Data
sets for all patients included age, gender, ethnicity, height, and
weight. To ensure a normal population, subjects in these studies
were excluded if any of the following criteria were met: systolic
blood pressure > 140 mm Hg, diastolic blood pressure > 80 mm
Hg, history of drug-treated hypertension, diagnosis of diabetes,
impaired fasting glucose > 100 mg/dL, body mass index > 30 kg/
m2, creatinine > 1.3 mg/dL, estimated glomerular filtration rate
<60mL/min/1.73m2, total cholesterol>240mg/dL, low-density lipo-
protein cholesterol > 130 mg/dL, and total triglycerides > 150 mg/dL.
Details of the statistical analysis are described in the Appendix. Because
of varied study aims, not all echocardiographic measurements were
available for each database. Supplemental Table 1 summarizes the sour-
ces of the data for each measurement group and their baseline charac-
teristics.
Table 2 shows the normal values for 2D echocardiographic param-
eters of LV size and function according to gender, while Supplemental
Table 2 provides expanded data for the same parameters, obtained
from different echocardiographic views, and also includes the
corresponding number of subjects used to obtain these data.
Supplemental Table 3 lists normal ranges and consensus-based parti-
tion cutoffs for LV dimensions, volumes, EF, and mass. On multivar-
iate analysis, age, gender, and BSA were found to have a significant
independent influence on LV end-diastolic volume (EDV) and LV
end-systolic volume (ESV). The results across genders and age deciles
subdivided into absolute and BSA-normalized values are shown in
Supplemental Table 4 (see Appendix).
Because ethnicity is an important factor, results of analysis by race
and gender are presented in Supplemental Table 5. From the regres-
sion analysis, nomograms are provided for plotting observed LV
dimensions versus BSA or BSA-indexed LV volumes versus age(Figures 1 and 2). Nomograms for absolute LV measurements
against age (Supplemental Figures 1 and 2) and BSA (Supplemental
Figures 3 and 4) are also provided (see Appendix).
1.4. Normal Reference Values for 3DE. Several studies have
published 3D echocardiographic reference values for healthy normo-
tensive subjects, which are summarized in Table 3.13 The reported
variations in the normal ranges from study to study are likely due to
differences in populations, echocardiographic equipment, and anal-
ysis software, as well as variability in measurement techniques. In
patients with good image quality, the accuracy of 3DE is comparable
with that of CMR, although volumes tend to be lower on echocardi-
ography.6
The effects of ethnicity on 3D echocardiographic LV volumes were
investigated in one study, which reported that LV volumeswere smaller
among Asian Indians than white Europeans, but EF did not differ
among ethnic groups.14 Inmost 3D echocardiographic studies, the rela-
tionship between age and 3D echocardiographic LV volumes was
examined, and weak to moderate negative correlations were seen be-
tween age and LV volumes, while EF did not change significantly with
age.10,15,16 This finding is similar to those described in the CMR
literature.17,18 On the basis of weighted averages of three
studies,16,19,20 3D echocardiographic LV volumes were larger than
2D echocardiographic values, and corresponding upper limits of the
normal range were EDVs of 79 mL/m2 for men and 71 mL/m2 for
women and ESVs of 32 mL/m2 for men and 28 mL/m2 for women.
Ultimately, a large study in a diverse population will be needed to
establish normal reference ranges for 3DE for different ethnic groups.
Recommendation. LV size should be routinely assessed on 2DE
by calculating volumes using the biplane method of disks summa-
tion technique. In laboratories with experience in 3DE, 3D
measurement and reporting of LV volumes is recommended
when feasible depending on image quality. When reporting LV
linear dimensions, the recommended method is 2D-guided
measurements. LV size and volume measurements should be
reported indexed to BSA. For general reference, 2D echocardio-
graphic LV EDVs of 74 mL/m2 for men and 61 mL/m2 for
women and LV ESVs of 31 mL/m2 for men and 24 mL/m2 for
women should be used as the upper limits of the corresponding
normal range.2. LV Global Systolic Function
Global LV function is usually assessed bymeasuring the difference be-
tween the end-diastolic and end-systolic value of a one-dimensional,
2D, or 3D parameter divided by its end-diastolic value. For this, end-
diastole is preferably defined as the first frame after mitral valve
closure or the frame in the cardiac cycle in which the respective LV
dimension or volume measurement is the largest. End-systole is best
defined as the frame after aortic valve closure or the frame in which
the cardiac dimension or volume is smallest. In patients with regular
heart rhythm, measurements of the timing of valve openings and clo-
sures derived fromM-mode echocardiography, pulsed-wave (PW) or
continuous-wave Doppler may be used for accurate definitions of
ventricular time intervals.
2.1. Fractional Shortening. Fractional shortening can be derived
from 2D-guided M-mode imaging or preferably from linear mea-
surements obtained from 2D images. Deriving global LV function
parameters from linear measurements is problematic when there
are regional wall motion abnormalities due to coronary disease or
Table 2 Normal values for 2D echocardiographic parameters of LV size and function according to gender
Parameter
Male Female
Mean 6 SD 2-SD range Mean 6 SD 2-SD range
LV internal dimension
Diastolic dimension (mm) 50.2 6 4.1 42.0–58.4 45.0 6 3.6 37.8–52.2
Systolic dimension (mm) 32.4 6 3.7 25.0–39.8 28.2 6 3.3 21.6–34.8
LV volumes (biplane)
LV EDV (mL) 106 6 22 62–150 76 6 15 46–106
LV ESV (mL) 41 6 10 21–61 28 6 7 14–42
LV volumes normalized by BSA
LV EDV (mL/m2) 54 6 10 34–74 45 6 8 29–61
LV ESV (mL/m2) 21 6 5 11–31 16 6 4 8–24
LV EF (biplane) 62 6 5 52–72 64 6 5 54–74
BSA, body surface area; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-stystolic volume; LV, left ventricular; SD, standard deviation.
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sion, obesity or valvular diseases, such regional differences are rare
in the absence of clinically recognized myocardial infarction, and
accordingly, this parameter may provide useful information in clin-
ical studies.21 In patients with normal size of the LV base but
enlarged midventricular and distal portions, LV volume would be
a better marker of LV size than linear dimension measured at the
LV base.
2.2. EF. EF is calculated from EDV and ESV estimates, using the
following formula:
EF ¼ ðEDV ESVÞ=EDV:
LV volume estimates may be derived from 2DE or 3DE, as
described above (section 1.2). The biplane method of disks (modified
Simpson’s rule) is the currently recommended 2D method to
assess LV EF by consensus of this committee. Table 4 lists 2DE-
derived biplane LV EF, including normal ranges and consensus-
based severity partition cutoffs according to gender. In patients with
good image quality, 3DE-based EF measurements are accurate and
reproducible and should be used when available and
feasible.6,10,15,16,19,20
2.3. Global Longitudinal Strain (GLS). Lagrangian strain is
defined as the change in length of an object within a certain direction
relative to its baseline length:
Strainð%Þ ¼ ðLt  L0Þ=L0;
where Lt is the length at time t, and L0 is the initial length at time 0. The
most commonly used strain-based measure of LV global systolic func-
tion is GLS. It is usually assessed by speckle-tracking echocardiography
(STE)22-24 (Table 1). On 2DE, peak GLS describes the relative length
change of the LVmyocardium between end-diastole and end-systole:
GLSð%Þ ¼ ðMLsMLdÞ=MLd;
whereML is myocardial length at end-systole (MLs) and end-diastole
(MLd). Because MLs is smaller than MLd, peak GLS is a negative
number. This negative nature of GLS can lead to confusion whendescribing increases or decreases in strain. We recommend that all ref-
erences to strain changes specifically mention an increase or decrease
in the absolute value of strain, to avoid confusion.
After optimizing image quality, maximizing frame rate, and mini-
mizing foreshortening, which are all critical to reduce measurement
variability, GLS measurements should be made in the three standard
apical views and averaged.25 Measurements should begin with the
apical long-axis view to visualize aortic valve closure, using opening
and closing clicks of the aortic valve or aortic valve opening and clos-
ing on M-mode imaging. When regional tracking is suboptimal in
more than two myocardial segments in a single view, the calculation
of GLS should be avoided. In such cases, alternative indices may be
used to gain insight into longitudinal LV function, such as mitral
annular plane systolic excursion or pulsed Doppler tissue imaging
(DTI)–derived mitral annular peak systolic velocity (s0).
There are concurrent definitions as a basis for GLS calculation us-
ing endocardial, midwall, or average deformation.24 This committee
refrains from recommendations in this regard and refers to the
ongoing joint standardization initiative of the ASE, EACVI, and the
ultrasound imaging industry.24,26 Because of intervendor and
intersoftware variability and age and load dependency, serial
assessment of GLS in individual patients should be performed using
the same vendor’s equipment and the same software.
The preponderance of currently available data is for midwall GLS.
Although the evidence base for its use in routine clinical echocardiog-
raphy is far smaller than that for EF, measures of midwall GLS have
been shown in several studies to be robust and reproducible27 and
to offer incremental predictive value in unselected patients undergoing
echocardiography for the assessment of resting function,28,29 as well as
in predicting postoperative LV function in patients with valve
disease.30,31
2.4. Normal Reference Values. Normal reference values for LV
EF derived from 2DE have been updated using the population-
based studies described in section 1.3 above. Details can be found
in Tables 2 and 4 and Supplemental Tables 2-5 (see Appendix). EF
is not significantly related to gender, age, or body size, as measured
by BSA. Normal EF was 63 6 5% using the biplane method of
disks. Therefore, in individuals aged > 20 years, EF in the range of
53% to 73% should be classified as normal. Three-dimensional
Figure 1 For men (left) and women (right), the 95% confidence intervals for the following measurements are presented: LV end-
diastolic dimension measured from a parasternal long-axis window on the basis of BSA (top), BSA-indexed LV EDV measured
from an apical four-chamber view on the basis of age (middle), and BSA-indexed biplane LV EDV on the basis of age (bottom).
For example, a normal BSA-indexed LV EDV measured from the four-chamber view in a 40-year-old woman would fall between
approximately 30 and 78 mL/m2.
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Figure 2 For men (left) and women (right), the 95% confidence intervals for the following measurements are presented: LV end-
systolic dimensions measured from a parasternal long-axis window on the basis of BSA (top), BSA-indexed LV ESVs measured
from an apical four-chamber view on the basis of age (middle), and BSA-indexed biplane LV ESVs based on age (bottom).
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different ethnic populations (Table 3).
Normal values for GLS depend on the definition of the measure-
ment position in the myocardium, the vendor, and the version ofthe analysis software, resulting in considerable heterogeneity in the
published literature.27,32,33 It is the consensus of this writing
committee that differences among vendors and software packages
are still too large to recommend universal normal values and lower
Table 3 Normal values for LV parameters obtained with 3DE
Aune et al. (2010) Fukuda et al. (2012) Chahal et al. (2012) Muraru et al. (2013)
Number of subjects 166 410 978 226
Ethnic makeup of population Scandinavian Japanese 51% European white, 49% Asian Indian White European
EDVi (mL/m2)
Men, mean (LLN, ULN) 66 (46, 86) 50 (26, 74) White: 49 (31, 67); Indian: 41 (23, 59) 63 (41, 85)
Women, mean (LLN, ULN) 58 (42, 74) 46 (28, 64) White: 42 (26, 58); Indian: 39 (23, 55) 56 (40, 78)
ESVi (mL/m2)
Men, mean (LLN, ULN) 29 (17, 41) 19 (9, 29) White: 19 (9, 29); Indian: 16 (6, 26) 24 (14, 34)
Women, mean (LLN, ULN) 23 (13, 33) 17 (9, 25) White: 16 (8, 24); Indian: 15 (7, 23) 20 (12, 28)
EF (%)
Men, mean (LLN, ULN) 57 (49, 65) 61 (53, 69) White: 61 (49, 73); Indian: 62 (52, 72) 62 (54, 70)
Women, mean (LLN, ULN) 61 (49, 73) 63 (55, 71) White: 62 (52, 72); Indian: 62 (52, 72) 65 (57, 73)
EDVi, LV EDV index; ESVi, LV ESV index; LLN, lower limit of normal; NR, not reported; RT3DTTE, real-time 3D TTE; SVi, LV stroke volume index;
ULN, upper limit of normal.
Modified with permission from Bhave et al.13 LLN and ULN are defined as mean 6 2 SDs.
Table 4 Normal ranges and severity partition cutoff values for 2DE-derived LV EF and LA volume
Male Female
Normal
range
Mildly
abnormal
Moderately
abnormal
Severely
abnormal
Normal
range
Mildly
abnormal
Moderately
abnormal
Severely
abnormal
LV EF (%) 52–72 41–51 30–40 <30 54–74 41–53 30–40 <30
Maximum LA volume/BSA (mL/m2) 16–34 35–41 42–48 >48 16–34 35–41 42–48 >48
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of20% can be expected in a healthy person. A selection of recently
published data is provided in the Appendix together with the lower
normal limits (Supplemental Table 6). There is evidence that women
have slightly higher absolute values of GLS than men and that strain
values decrease with age.32,34 GLS is a valuable and sensitive tool for
follow-up examinations, provided the same equipment, tracing meth-
odology, and software are used.
Recommendations. LV systolic function should be routinely as-
sessed using 2DE or 3DE by calculating EF from EDV and ESV. LV
EFs of <52% for men and <54% for women are suggestive of
abnormal LV systolic function. Two-dimensional STE-derived GLS ap-
pears to be reproducible and feasible for clinical use and offers incre-
mental prognostic data over LV EF in a variety of cardiac conditions,
although measurements vary among vendors and software versions.
To provide some guidance, a peak GLS in the range of 20% can
be expected in a healthy person, and the lower the absolute value
of strain is below this value, the more likely it is to be abnormal.3. LV Regional Function
3.1. Segmentation of the Left Ventricle. For the assessment of
regional LV function, the ventricle is divided into segments.
Segmentation schemes should reflect coronary perfusion territories,
result in segments with comparable myocardial mass, and allow
standardized communication within echocardiography and withother imaging modalities (Figure 3). Accordingly, a 17-segment
model is commonly used. Beginning at the anterior junction of
the interventricular septum and the RV free wall and continuing
counterclockwise, basal and midventricular segments should be
labeled as anteroseptal, inferoseptal, inferior, inferolateral, anterolat-
eral, and anterior. In this 17-segment model, the apex is divided into
five segments, including septal, inferior, lateral, and anterior seg-
ments, as well as the ‘‘apical cap,’’ which is defined as the myocar-
dium beyond the end of the LV cavity (Figures 3 and 4).35 The
17-segment model may be used for myocardial perfusion studies
or when comparing between different imaging modalities, specif-
ically single photon-emission computed tomography, positron emis-
sion tomography, and CMR. Figure 5 shows a schematic
representation of the perfusion territories of the three major coro-
nary arteries. When using this 17-segment model to assess wall
motion or regional strain, the 17th segment (the apical cap) should
not be included.
Alternative segmentation models treat the apex differently: the 16-
segment model36 divides the entire apex into the same four segments
(septal, inferior, lateral, and anterior; Figure 3, left). Also, some seg-
mentation schemes divide the apex into six segments, similar to the
basal and midventricular levels, resulting in an 18-segment model
(Figure 3, right) that is simple but results in a slight overrepresentation
of the distal myocardium when scoring.
All segments can be visualized by 2DE. On average, the two-
chamber view and the apical long-axis view intersect with the
four-chamber view at angles of approximately 53 and 129,
Figure 3 Schematic diagram of the different LV segmentation models: 16-segment model (left),36 17-segment model (center),35 and
18-segment model (right). In all diagrams, the outer ring represents the basal segments, themiddle ring represents the segments at mid-
papillary muscle level, and the inner ring represents the distal level. The anterior insertion of the right ventricular wall into the left ventricle
defines the border between the anteroseptal and anterior segments. Starting from this point, themyocardium is subdivided into six equal
segments of 60. The apical myocardium in the 16- and 17-segment models is divided instead into four equal segments of 90. In the
17-segment model an additional segment (apical cap) is added in the center of the bull’s-eye. (modified from Voigt et al.24).
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ments from an apical window, independent of the model used.
Although certain variability exists in the coronary artery blood supply
to myocardial segments, segments are usually attributed to the three
major coronary arteries (Figure 5).35
3.2. Visual Assessment. In echocardiography, regional myocar-
dial function is assessed on the basis of the observed wall thickening
and endocardial motion of the myocardial segment. Because myocar-
dial motion may be caused by adjacent segment tethering or overall
LV displacement, regional deformation (thickening, shortening)
should be the focus of the analysis. However, it must be recognized
that deformation can also be passive and therefore may not always
accurately reflect myocardial contraction.
It is recommended that each segment be analyzed individually in
multiple views. A semiquantitative wall motion score can be assigned
to each segment to calculate the LV wall motion score index as the
average of the scores of all segments visualized. The following scoring
system is recommended: (1) normal or hyperkinetic, (2) hypokinetic
(reduced thickening), (3) akinetic (absent or negligible thickening, e.g.,
scar), and (4) dyskinetic (systolic thinning or stretching, e.g., aneu-
rysm).
An aneurysm is a morphologic entity that demonstrates focal dila-
tation and thinning (remodeling) with either akinetic or dyskinetic sys-
tolic deformation.38 In contrast to the recommendation of previous
guidelines,1,2 this committee refrains from assigning a separate wall
motion score for aneurysm.
3.3. Regional Wall Motion during Infarction and
Ischemia. Depending on the regional coronary flow reserve, stress
echocardiography may reveal significant coronary artery stenoses by
means of inducing a wall motion abnormality. Myocardial scar
may also result in regional dysfunction of variable severity.Echocardiography can over- or underestimate the amount of ischemic
or infarcted myocardium, depending on the function of adjacent re-
gions, regional loading conditions, and stunning.39 In stress echocardi-
ography, visual recognition of regional dysfunction can be improved
with a synchronized side-by-side comparison of baseline and stress
images using digital technology.40
3.4. Regional Abnormalities in the Absence of Coronary Ar-
tery Disease. Regional wall motion abnormalities may also occur in
the absence of coronary artery disease, in a variety of conditions, such
as myocarditis, sarcoidosis, and stress-induced (takotsubo) cardiomy-
opathy. Abnormal motion patterns of the interventricular septum
may be found postoperatively or in the presence of a left bundle
branch block or RV epicardial pacing, as well as RV dysfunction
caused by RV pressure or volume overload. Furthermore, some con-
duction delays can cause regional wall motion abnormalities in the
absence of primary myocardial dysfunction. This regional dysfunction
is due to the abnormal sequence of myocardial activation, which
causes heterogeneous loading conditions and remodeling.41 Ideally,
the temporal sequence of activation and motion should be described.
Characteristic motion patterns, which result from abnormal activation
sequences, such as septal bounce (‘‘beaking,’’ ‘‘flash’’) or lateral apical
motion during systole (‘‘apical rocking’’) should be reported.42-45
3.5. Quantification of Regional Wall Motion Using Doppler
and STE. Echocardiographic quantification of regional myocardial
function is currently based on DTI or speckle-tracking echocardio-
graphic techniques.46-48 Both techniques provide comparable data
quality, although DTI is known to be angle dependent and prone to
underestimating motion that is not parallel to the ultrasound beam.
Commonly used parameters include velocity, motion, deformation,
and deformation rate. Because velocity and motion are measured
relative to the transducer, measurements may be influenced by
Figure 4 Orientation of apical four-chamber (A4C), apical two-chamber (A2C), and apical long-axis (ALX) views in relation to the
bull’s-eye display of the LV segments (center). Top panels show actual images, and bottom panels schematically depict the LV
wall segments in each view.
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parameters, such as strain and strain rate, is preferable.
The most commonly used deformation parameter is longitudinal
strain during LV systole. Similar to global strain, with current technol-
ogy, regional deformation measurements may vary in amplitude,
depending on the myocardial region being investigated, the measure-
ment methodology, the vendor, and sample volume definition.
Therefore, no specific normal ranges are provided in this document.
These values await the upcoming consensus document of the joint
task force of the ASE, EACVI, and the industry for the standardization
of quantitative function imaging.23,25
Independent of strain magnitude, characteristic changes in tempo-
ral pattern of myocardial deformation can be assessed as well.
Longitudinal shortening or radial thickening of the myocardium after
aortic valve closure (postsystolic shortening or thickening, sometimes
referred to as tardokinesis) of >20% of the total deformation during
the cardiac cycle is a consistent sign of regional functional inhomoge-
neity (e.g., ischemia, scar).44 The development of postsystolicshortening during a stress test has been proposed as an indicator of
regional ischemia.49 The value of regional deformation parameters
and temporal patterns of strain derived by speckle-tracking from
either 2D or 3D echocardiographic data sets is the subject of ongoing
research and remains to be determined.50,51
Recommendations. Different LV segmentation models are used
in clinical practice. The 17-segment model is recommended to assess
myocardial perfusion with echocardiography and other imaging tech-
niques. The 16-segment model is recommended for routine studies
assessing wall motion, because endocardial excursion and thickening
of the tip of the apex are imperceptible. To assess wall motion, each
segment should be evaluated in multiple views and a four-grade
scoring should be applied: (1) normal or hyperkinetic, (2) hypokinetic
(reduced thickening), (3) akinetic (absent or negligible thickening),
and (4) dyskinetic (systolic thinning or stretching). Despite promising
data, quantitative assessment of the magnitude of regional LV defor-
mation cannot be recommended at this stage because of lack of
Figure 5 Typical distributions of the right coronary artery (RCA), the left anterior descending coronary artery (LAD), and the circumflex
coronary artery (CX). The arterial distribution varies among patients. Some segments have variable coronary perfusion.
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vendor measurement variability.4. LV Mass
LV mass is an important risk factor for, and a strong predictor of, car-
diovascular events.52-55 There are several methods that effectively
calculate LV mass from M-mode echocardiography, 2DE, and 3DE
(Table 5). All measurements should be performed at the end of dias-
tole (the frame before mitral valve closure or the frame in the cardiac
cycle in which the ventricular dimension or volume is largest). Those
that use M-mode (either blinded or 2D-guided) and 2D echocardio-
graphic linear measurements of LV diastolic diameter and wall thick-
ness rely on geometric formulas to calculate the volume of LV
myocardium, while 3DE can measure it directly. All methods then
convert the volume to mass by multiplying the volume of myocar-
dium by the myocardial density (approximately 1.05 g/mL).
When the entire ventricle is measured from 2D echocardiographic
images, either the area-length or truncated ellipsoid technique is
used.1 Each method for LVmass measurement has advantages, disad-
vantages, and value in specific situations (Table 5).
To measure LV mass in an individual patient over time, especially
those with cardiac disease, the 2D echocardiographic methods have
advantages compared with the linear dimension technique.1 There
are, however, fewer studies of the prognostic value of LV mass calcu-
lated by these methods compared with the linear dimension method
described below. Unlike the linear dimension orM-modemethod, the
2D echocardiographic methods can accommodate for the shape of
the ventricle and account for changes in LV size that might occur
along the long axis of the chamber. This is an important consideration,
because changes in LV geometry are common in various cardiac dis-
eases.
However, when there is a need to screen or study large popula-
tions, theM-modemethod has advantages, because it is simple, quick,
and subject to less measurement variability. There is a large body of
evidence to support the accuracy of this method. Most studies that
relate LV mass to prognosis are based on this method.56 However,several caveats need to be mentioned. First, it is critical that the wall
thickness and LV dimensions measured be truly perpendicular to
the long axis of the left ventricle. Therefore, 2D-guided M-mode im-
aging or measurements from 2D echocardiographic images are
preferred over blind M-mode imaging. Second, the formula includes
a correction for the 20% overestimation that was found during the
original validation studies of the M-mode technique. Because direct
2D measures of wall thickness may yield smaller values than the
M-mode technique, LV mass calculated using this formula may not
be directly interchangeable (Table 5). This may be a less important
consideration if the method is being used to identify cutoff values
for prognosis. It is also important to note that the formula raises the
linear dimensions to the power of 3, and thus even small errors in di-
mensions can have significant effects on the calculated LV mass.
Most studies that have compared 2D-guided M-mode measure-
ments of LV mass with the 2D echocardiographic area-length or trun-
cated ellipsoid methods in normally shaped ventricles have shown
subtle differences but no clear advantage of one technique over the
other.57 However, comparison studies have not been performed in
the current era, when tremendous gains in 2D echocardiographic im-
age quality have been made. In fact, large population studies confirm-
ing or reestablishing normal values for LV mass with harmonic
imaging are limited.58,59
Because 3DE is the only echocardiographic method that directly
measures myocardial volume, it is an appropriate approach.
Numerous validation studies have been performed.60 However, to
date, there have been few studies assessing its practical use, feasibility,
variability, or prognostic value in large-scale clinical environments.61
Accordingly, it is the consensus of this committee that the 3D echo-
cardiographic LV mass data available in normal subjects are not suffi-
cient to recommend normal reference values. It must also be noted
that continuous improvements in the spatial and temporal resolution
of 3D echocardiographic imaging will also influence normal values
and measurement variability.
In patients with upper septal hypertrophy, the linear dimension
methods, which use basal ventricular measurements, result in over-
estimation of the true mass, because the thickest region of the
Table 5 Recommendations for the echocardiographic assessment of LV mass
Parameter and method Echocardiographic imaging Advantages Limitations
Linear method:
Cube formula
LV mass ¼ 0:8$1:04$½ðIVS
þLVIDþ PWTÞ3LVID3
i
þ 0:6g
Where IVS is interventricular septum; LVID
is LV internal diameter, and PWT is
inferolateral wall thickness.
Linear internal measurements of the LV
should be acquired from the parasternal
approach and carefully obtained
perpendicular to the LV long axis, and
measured at the level of the mitral valve
leaflet tips. M-mode measurements should
be obtained from a targeted SAX or a
parasternal LAX view. All measurements
should be performed at end-diastole.
M-mode tracing
2D
 Fast and widely used
 Wealth of published data
 Demonstrated prognostic value
 Fairly accurate in normally shaped ven-
tricles (i.e., systemic hypertension, aortic
stenosis)
 Simple for screening large populations
 Facilitates orientation perpendicular to
the LV long axis
 Based on the assumption that the left
ventricle is a prolate ellipsoid with a 2:1
long/short axis ratio and symmetric dis-
tribution of hypertrophy
 Beam orientation frequently off axis
 Since linear measurements are cubed,
even small measurement errors in di-
mensions or thickness have an impact on
accuracy
 Overestimates LV mass
 Inaccurate in the presence of asymmetric
hypertrophy, dilated ventricles and other
diseases with regional variations in wall
thickness
 Based on the same geometrical as-
sumptions as M-mode
 Same limitations as M-mode in patients
with abnormal LV geometry
 Impact of harmonic imaging on the mass
calculations and normal values remains
to be defined
 Normal values are less well established
than for M-mode measurements
2D based formulas.
Truncated ellipsoid:
LV mass ¼ 1:05p
(
ðbþ tÞ2
"
2
3
ðaþ tÞ þ d  d
3
3ðaþ tÞ2
#
b2

2
3
aþ d  d
3
3a2
)
 Partial correction for shape distortions
 Less dependent on geometrical as-
sumptions than the linear measurements
 Good image quality and properly oriented
parasternal short-axis views (no oblique
planes) are required
 Good epicardial definition is required
 Cumbersome methodology
 Higher measurement variability
 Few published normative data
 Limited prognostic data
(Continued )
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Table 5 (Continued )
Parameter and method Echocardiographic imaging Advantages Limitations
Area-length:
LV mass ¼ 1:05
5
6
A1ðaþ d þ tÞ



5
6
A2ðaþ dÞ

Mean wall thickness is calculated from
epicardial (A1) and endocardial (A2) cross-
sectional areas in short-axis view at the
papillary muscle level (top panel, green line)
with the papillary muscles considered part
of the LV cavity. The short axis radius is
calculated as:
b
ﬃﬃﬃﬃ
A2
p
q
Then,meanwall thickness t is calculated as:
t ¼
 ﬃﬃﬃﬃ
A1
p
q !
 b
and the cross sectional area of the
myocardium (Am) in short-axis view is:
Am ¼ A1  A2
LV mass is calculated from these
measurements plus the LV lengthmeasured
from the level of the short axis plane to the
base (d) and to the apex (a).
Key: a - distance from the minor axis to the
endocardium at the LV apex; b = LV minor
radius; d - distance from the minor axis to
the mitral valve plane; t - mean wall
thickness.
LV mass = (LV epicardial volume  LV
endocardial volume). 1.05 = LV myocardial
volume. 1.05
LV mass = (LV epicardial volume  LV
endocardial volume). 1.05 = LV myocardial
volume. 1.05
3D based formula. 3D data set  Direct measurement without geometrical
assumptions about cavity shape and hy-
pertrophy distribution
 More accurate than the linear or the 2D
measurements
 Higher inter-measurement and test/re-
test reproducibility
 Better discriminates small changes within
a patient
 Normal values less well established
 Dependent on image quality
 Patient’s cooperation required
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January 2015interventricular septum is incorporated in the measurement. In
contrast, the area-length method, which uses mid-ventricular mea-
surements, underestimates LV mass, because the thickest part of
the interventricular septum is not included in the measurement. In
the setting of discrete upper septal or asymmetric hypertrophy, if
these methods are used to serially assess LV mass in a patient, it is
critical to use the same methodology over time and to measure
the walls at the same level of the ventricle. The 3D method has
the advantage of accommodating regional differences in wall thick-
ness and therefore can provide the most accurate measurements of
LV mass in this setting.
The values for LV mass vary according to gender, age, body size,
obesity, and region of the world. Therefore, uniform reference values
are difficult to define. LV mass is higher in men independent of body
size and increases with body size. Since the publication of the 2005 rec-
ommendations, several studies,mostly using linearmeasurements, have
reported normal values of LV mass in normal populations.59,62-66 The
larger studies reported values close to those recommended in the
previous guidelines.62,65,66 Therefore, the same reference values and
abnormality partition cutoffs as reported in the previous guidelines
continue to be recommended (Table 6). However, characterization of
the population being studied, and differences inmass betweendifferent
ethnic populations should be taken into account when determining
normal values.10,16,67-69
The indexing of LV mass allows comparisons in subjects with
different body sizes. However, whether to use height, weight, or
BSA as the indexing term remains controversial. Studies suggest
that indexing to height raised to allometric powers such as 1.7, 2.13,
and 2.7 has advantages over indexing to BSA, especially when at-
tempting to predict events in obese patients.65,70 However most
large population studies reporting LV mass have indexed to BSA.
Finally, calculation of relative wall thickness (RWT) with the for-
mula (2  posterior wall thickness)/(LV internal diameter at end-
diastole) permits categorization of an increase in LV mass as either
concentric (RWT > 0.42) or eccentric (RWT # 0.42) hypertrophy
and allows the identification of concentric remodeling (normal LV
mass with increased RWT) (Figure 6).
Recommendations. In the normally shaped left ventricle, both
M-mode and 2D echocardiographic formulas to calculate LV mass
can be used. Normal values for these techniques remain unchanged
from the previous guidelines and should be reported indexed to
BSA. Reference upper limits of normal LV mass by linear measure-
ments are 95 g/m2 in women and 115 g/m2 in men. Reference up-
per limits of normal LV mass by 2D measurements are 88 g/m2 in
women and 102 g/m2 in men with 2D methods. Because 3DE is
the only echocardiographic technique that measures myocardial vol-
ume directly, without geometric assumptions regarding LV shape
and distribution of wall thickening, this technique is promising and
may be used in abnormally shaped ventricles or in patients with
asymmetric or localized hypertrophy. Limited upper normal limits
of 3D echocardiographic LV mass data are currently available in
the literature but are insufficient to substantiate recommendations
for reference values.II. THE RIGHT VENTRICLE
The right ventricle has a unique crescent shape, which adds
complexity to the quantification of its size and function. This chamber
plays an important role in the morbidity and mortality of patients pre-senting with signs and symptoms of cardiopulmonary disease. Until
recently, little uniformity in echocardiographic imaging of the right
heart existed because of a lack of familiarity with various techniques,
and the enormous attention directed toward left heart quantification.
The ASE has recently published a guidelines document, endorsed by
the EACVI and the Canadian Society of Echocardiography, standard-
izing the approach for the evaluation of right heart dimensions and
function during echocardiographic assessment of the right heart in
adults.71 Compared with that document, this section provides up-
dated reference values for RV dimensions and most parameters of
systolic and diastolic function, which should replace the previously
published guideline.5. General Recommendations for RV Quantification
In all clinical studies, a comprehensive examination of the right
ventricle should be performed, taking into account the study indica-
tion and available clinical information. The operator should examine
the right ventricle using multiple acoustic windows, and the report
should present an assessment based on both qualitative and quantita-
tive parameters. Parameters that can be measured include RV and
right atrial (RA) size, a measure of RV systolic function, as assessed
by at least one or a combination of the following: fractional area
change (FAC), DTI-derived tricuspid lateral annular systolic velocity
wave (S0), tricuspid annular plane systolic excursion (TAPSE), and
RV index of myocardial performance (RIMP). RV systolic pressure,
typically calculated using the tricuspid regurgitation jet and an estima-
tion of RA pressure based on inferior vena cava (IVC) size and collaps-
ibility, should be reported when a complete TR Doppler velocity
envelope is present.71 When feasible, additional parameters such as
RV volumes and EF using 3DE should complement the basic 2D
echocardiographic measurements listed above. The recommended
methods, as well as the advantages and limitations of each parameter,
are summarized in Tables 7 and 9, whereas the new reference values
are displayed in Tables 8 and 10. These reference values are based on
published mean and SD data obtained from normal adult individuals
without any histories of heart or pulmonary disease (Supplemental
Table 7). This document uses the same methodology as in the previ-
ous RV guidelines, whereby a meta-analysis was performed for each
parameter.
Not all of the recommended values are identical to those published
in the previous guidelines.71 On the basis of the inclusion of new data
published in recent reports, minor changes were made in the cutoff
values for RV dimension, S0, TAPSE, and RIMP. New publications
since the last guidelines have resulted in changes in the reference
values for 3DE-derived RV EF and volumes (Tables 8 and 10). It is
important for the reader to recognize that most of the values
proposed are not indexed to gender, BSA, or height, despite data
suggesting the advantages of indexing.72-75 As a result, it is possible
that patients at either extreme of height or BSA may be
misclassified as having values outside the reference ranges, and it is
recommended that the interpreting physician consider these
parameters when generating the report. This potential
misclassification also applies to other groups, such as patients with
congenital heart disease and endurance athletes, for whom specific
reference values are nonexistent.766. Essential Imaging Windows and Views
Apical four-chamber, RV-focused apical four-chamber and modified
apical four-chamber (Figure 7A), left parasternal long- and
Table 6 Normal ranges for LV mass indices
Women Men
Linear method
LV mass (g) 67–162 88–224
LV mass/BSA (g/m2) 43–95 49–115
Relative wall thickness (cm) 0.22–0.42 0.24–0.42
Septal thickness (cm) 0.6–0.9 0.6–1.0
Posterior wall thickness (cm) 0.6–0.9 0.6–1.0
2D method
LV mass (g) 66–150 96–200
LV mass/BSA (g/m2) 44–88 50–102
Bold italic values: recommended and best validated.
Figure 6 Comparison of RWT. Patients with normal LV mass
can have either concentric remodeling (normal LV mass with
increased RWT $ 0.42) or normal geometry (RWT # 0.42) and
normal LV mass. Patients with increased LV mass can have
either concentric (RWT$ 0.42) or eccentric (RWT# 0.42) hyper-
trophy. These LVmass measurements are based on linear mea-
surements.
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images required for a comprehensive assessment of RV size, systolic
and diastolic function, and RV systolic pressures.71 In most cases, in
the RV-focused view, visualization of the entire RV free wall is better
than in a standard four-chamber view, which is centered on the left
ventricle. It is therefore recommended that to measure the right
ventricle, a dedicated view focused on the right ventricle be used.
Figure 7A and Table 7 show the different RV views and recommen-
dations for measurements.7. RV Measurements
7.1. Linear Measurements. Quantitation of RV dimensions is
critical and reduces interreader variability compared with visual
assessment alone.77 Measurements by 2DE are challenging because
of the complex geometry of the right ventricle and the lack of spe-
cific right-sided anatomic landmarks to be used as reference points.
The conventional apical four-chamber view (i.e., focused on the left
ventricle) results in considerable variability in how the right heart is
sectioned, and consequently, RV linear dimensions and areas may
vary widely in the same patient with relatively minor rotations in
transducer position (Figure 7B). RV dimensions are best estimated
from a RV-focused apical four-chamber view obtained with either
lateral or medial transducer orientation (Figure 7A and Table 7).
Care should be taken to obtain the image with the LV apex at the
center of the scanning sector, while displaying the largest basal RV
diameter and thus avoiding foreshortening. Of note, the accuracy
of RV measurements may be limited when the RV free wall is
not well defined because of the dimension of the ventricle itself
or its position behind the sternum. Recent data have suggested
that indexing RV ‘‘size’’ to BSA may be relevant in some circum-
stances, but the measurements used in those studies lacked the
reference points of the RV-focused view and frequently used RV
areas, rather than linear dimensions.73,74 Reference values for RV
dimensions are listed in Table 8. In general, a diameter >41 mm
at the base and >35 mm at the midlevel in the RV-focused view in-
dicates RV dilatation.
7.2. Volumetric Measurements. Three-dimensional echocardi-
ography allows measurements of RV volumes (Figure 8), thereby
overcoming the limitations of conventional 2DE RV views with
respect to orientation and reference points. Although technically chal-
lenging, particularly in patients with imperfect image quality orseverely enlarged right ventricles, a reasonably accurate estimate of
RV EDV and ESV can be obtained, and RV EF can be calculated.
Practical recommendations regarding RV 3D imaging and analysis
have been recently published by the European Association of
Echocardiography and the ASE.61 During analysis of RV volume, it
is critically important to manually define end-diastolic and end-
systolic frames using maximal and minimal RV volumes, respectively,
rather than LV chamber changes (Table 7). Myocardial trabeculae and
the moderator band should be included in the cavity, and RV con-
tours on dynamic images should closely follow endocardial displace-
ment and excursion of the tricuspid annulus throughout the cardiac
cycle.
Even though 3DE tends to underestimate RV volumes compared
CMR,78 3DE has identified relationships between RV volumes and
EF to age and gender, which are very similar to those described by
CMR.72 Overall, women have smaller 3D echocardiographic RV vol-
umes, despite indexing toBSA, andhigherEFs.75Also, older age is asso-
ciated with smaller volumes (expected decrements of 5 mL/decade
for EDV and 3 mL/decade for ESV) and higher EF (an expected
increment of 1% per decade).75 Reference values of 3DE-derived
RV volumes (indexed to BSA) and EF obtained from the meta-
analyses of all studies are summarized in Tables 8 and 10. Details
of the above-described study factoring in age, gender, and BSA
are listed in Supplemental Table 8.75 Although RV volumes by
CMR appear to be significantly influenced by race,72 no 3D echo-
cardiographic data are yet available.
Recommendations. RV size should be routinely assessed by con-
ventional 2DE using multiple acoustic windows, and the report
should include both qualitative and quantitative parameters. In labo-
ratories with experience in 3DE, when knowledge of RV volumes
may be clinically important, 3D measurement of RV volumes is rec-
ommended. Although normal 3D echocardiographic values of RV
volumes need to be established in larger groups of subjects, current
published data suggest RV EDVs of 87 mL/m2 in men and 74 mL/m2
Table 7 Recommendations for the echocardiographic assessment of RV size
Echocardiographic imaging Recommended methods Advantages Limitations
RV linear dimensions (inflow)*  Basal RV linear dimension
(RVD1) = maximal transversal
dimension in the basal one
third of RV inflow at end-
diastole in the RV-focused
view
 Mid-cavity RV linear dimen-
sion (RVD2) = transversal RV
diameter in the middle third of
RV inflow, approximately
halfway between the maximal
basal diameter and the apex,
at the level of papillary mus-
cles at end-diastole.
 Easily obtainable
 Simple
 Fast
 Wealth of published data
 RV size may be underesti-
mated due to the crescent RV
shape
 RV linear dimensions are
dependent on probe rotation
and different RV views; in or-
der to permit inter-study
comparison, the
echocardiography report
should state the window from
which the measurement was
performed.
RV linear dimensions
(outflow)*
 Proximal RV outflow diameter
(RVOT prox) = linear dimen-
sion measured from the
anterior RV wall to the inter-
ventricular septal-aortic
junction (in parasternal long-
axis view) or to the aortic
valve (in parasternal short-
axis) at end-diastole
 Distal RV outflow diameter
(RVOT distal) = linear trans-
versal dimension measured
just proximal to the pulmo-
nary valve at end-diastole
 Easily obtainable
 Simple
 Fast
 RVOT prox is dependent on
imaging plane position and
less reproducible than RVOT
distal
 Risk of underestimation or
overestimation if the RV view
is obliquely oriented with
respect to RV outflow tract
 RV outflow dimensions can
be inaccurate in case of chest
and spine deformities
 Endocardial definition of the
RV anterior wall is often sub-
optimal
 Limited normative data is
available
 Regional measure; may not
reflect global RV size (under-
estimation or overestimation)
RV areas (inflow)  Manual tracing of RV endo-
cardial border from the lateral
tricuspid annulus along the
free wall to the apex and back
to medial tricuspid annulus,
along the interventricular
septum at end-diastole and at
end-systole
 Trabeculations, papillary
muscles and moderator band
are included in the cavity area
 Relatively easy to measure  Challenging in case of sub-
optimal image quality of RV
free wall
 Challenging in the presence
of trabeculation
 RV size underestimation if RV
cavity is foreshortened
 Due to the LV twisting motion
and the crescent RV shape,
the end-diastolic RV image
may not be in the same
tomographic plane as the
end-systolic one
 May not accurately reflect
global RV size (underestima-
tion or overestimation)
(Continued )
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Table 7 (Continued )
Echocardiographic imaging Recommended methods Advantages Limitations
3DE RV volumes  Dedicated multibeat 3D
acquisition, with minimal
depth and sector angle (for a
temporal resolution > 20–25
volumes/sec) that encom-
passes entire RV cavity
 Automatically identified
timing of end-diastole and
end-systole should be verified
 Myocardial trabeculae and
moderator band should be
included in the cavity
 Unique measures of RV
global size that includes
inflow, outflow and apical re-
gions
 Independent of geometric
assumptions
 Validated against cardiac
magnetic resonance
 Dependent on image quality,
regular rhythm, patient coop-
eration
 Needs specific 3D echocar-
diographic equipment and
training
 Reference values established
in few publications
RV wall thickness  Linear measurement of RV
free wall thickness (either by
M-mode or 2DE) performed at
end-diastole, below the
tricuspid annulus at a
distance approximating the
length of anterior tricuspid
leaflet, when it is fully open
and parallel to the RV free
wall.
 Trabeculae, papillary muscles
and epicardial fat should be
excluded
 Zoomed imaging with focus
on the RV mid-wall and
respiratory maneuvers may
improve endocardial border
definition
 Easy to perform  Single-site measurement
 Harmonic imaging and obli-
que M-mode sampling may
overestimate RV wall thick-
ness
 Challenging in case of thick-
ening of visceral pericardium
 There is no criterion for
defining an abnormally thin
RV wall
*All linear dimensions should be obtained using inner-edge-to-inner-edge method.
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women as the upper limits of the corresponding normal ranges.8. RV Systolic Function
RV systolic function has been evaluated using multiple parameters
(Table 9), including RIMP, TAPSE, 2D FAC, 3DE EF, S0, and lon-
gitudinal strain and strain rate by DTI and 2D STE.25 Multiple
studies have demonstrated the clinical utility and value of RIMP,
TAPSE, 2D FAC, and S0 of the tricuspid annulus, as well as longi-
tudinal speckle-tracking echocardiographic strain. RV EF by 3DE
seems to be more reliable and have better reproducibility when
properly performed, and a growing body of data are currently
available to provide normal reference values (Table 10 and
Supplemental Table 8).
8.1. RIMP. RIMP is an index of global RV performance. The isovo-
lumic contraction time, the isovolumic relaxation time, and ejection
time intervals should be measured from the same heartbeat using
either PW spectral Doppler or DTI velocity of the lateral tricuspid
annulus (Table 9). When using PW spectral Doppler to calculate
RIMP, it important to ensure that the nonconsecutive beats have
similar RR intervals. This limitation does not apply to the DTI-based
RIMP measurements. RIMP can be falsely low in conditionsassociated with elevated RA pressures, which will shorten the
IVRT. RIMP > 0.43 by PW Doppler and > 0.54 by DTI indicate
RV dysfunction.
8.2. TAPSE. TAPSE is easily obtainable and represents a measure of
RV longitudinal function. It is measured by M-mode echocardiogra-
phy with the cursor optimally aligned along the direction of the
tricuspid lateral annulus in the apical four-chamber view (Table 9).
Although this index predominantly reflects RV longitudinal function,
it has shown good correlations with parameters estimating RV global
systolic function, such as radionuclide-derived RV EF, 2D echocardio-
graphic RV FAC, and 2D echocardiographic EF. As a one-dimensional
measurement relative to the transducer position, TAPSE may over- or
underestimate RV function because of cardiac translation.79
Although there may be minor variations in TAPSE values according
to gender and BSA, generally, TAPSE < 17 mm is highly suggestive
of RV systolic dysfunction.
8.3. RV 2D FAC. FAC provides an estimate of global RV systolic
function. It is important to ensure that the entire right ventricle be con-
tained in the imaging sector, including the apex and the free wall, dur-
ing both systole and diastole. While tracing the RVarea, care must be
taken to include the trabeculae in the RV cavity (Table 9). RV FAC
< 35% indicates RV systolic dysfunction.
Table 8 Normal values for RV chamber size
Parameter Mean 6 SD Normal range
RV basal diameter (mm) 33 6 4 25-41
RV mid diameter (mm) 27 6 4 19-35
RV longitudinal diameter (mm) 71 6 6 59-83
RVOT PLAX diameter (mm) 25 6 2.5 20-30
RVOT proximal diameter (mm) 28 6 3.5 21-35
RVOT distal diameter (mm) 22 6 2.5 17-27
RV wall thickness (mm) 3 6 1 1-5
RVOT EDA (cm2)
Men 17 6 3.5 10-24
Women 14 6 3 8-20
RV EDA indexed to BSA (cm2/m2)
Men 8.8 6 1.9 5-12.6
Women 8.0 6 1.75 4.5-11.5
RV ESA (cm2)
Men 9 6 3 3-15
Women 7 6 2 3-11
RV ESA indexed to BSA (cm2/m2)
Men 4.7 6 1.35 2.0-7.4
Women 4.0 6 1.2 1.6-6.4
RV EDV indexed to BSA (mL/m2)
Men 61 6 13 35-87
Women 53 6 10.5 32-74
RV ESV indexed to BSA (mL/m2)
Men 27 6 8.5 10-44
Women 22 6 7 8-36
EDA, end-diastolic area; ESA, end-systolic area; PLAX, parasternal
long-axis view; RVOT, RV outflow tract.
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Velocity. DTI-derived S0-wave velocity is easy to measure, reliable,
and reproducible, and it has been shown to correlate well with other
measures of global RV systolic function. Specific age-related cutoff
values have been reported in a large sample of healthy subjects.80 It
is important to keep the basal segment and the annulus aligned
with the Doppler cursor to avoid velocity underestimation
(Table 9). Similar to TAPSE, S0 is measured relative to the transducer
andmay therefore be influenced by overall heart motion. An S0 veloc-
ity < 9.5 cm/sec measured on the free-wall side indicates RV systolic
dysfunction.
8.5. RV Strain and Strain Rate. Strain and strain rate are useful
parameters for estimating RV global and regional systolic function.
Longitudinal strain is calculated as the percentage of systolic short-
ening of the RV free wall from base to apex, while longitudinal
strain rate is the rate of this shortening. RV longitudinal strain is
less confounded by overall heart motion79,81 but depends on RV
loading conditions as well as RV size and shape. RV longitudinal
strain should be measured in the RV-focused four-chamber view.
Compared with STE-derived strain, the angle dependency of DTI
strain is a disadvantage. RV speckle-tracking echocardiographic
strain is influenced by image quality, reverberation and other arti-
facts, as well as attenuation. Placing the basal reference points too
low (i.e., on the atrial side of the tricuspid annulus) might result inartifactually low basal strain values. The width of the region of in-
terest should be limited to the myocardium, excluding the pericar-
dium, which may be difficult given the usually thin RV free wall
(Table 9).
In the context of the right ventricle, GLS is a parameter borrowed
from LV measurements, and software currently used to measure RV
GLS from most manufacturers has been designed for LV measure-
ments and later adapted for the right ventricle. The term RV GLS usu-
ally refers to either the average of the RV free wall and the septal
segments or the RV free wall segments alone (Figure 9). Peak global
longitudinal RV strain excluding the interventricular septum has
been recently reported to have prognostic value in various disease
states, such as heart failure,82,83 acute myocardial infarction,84 pulmo-
nary hypertension,85,86 and amyloidosis,87 and to predict RV failure
after LV assist device implantation.88
The largest body of evidence comes from the single-center studies
cited above, which involved predominantly imaging equipment and
software from two vendors, where pooled data were derived from
limited number of subjects. Current reference values for global RV
free wall speckle-tracking echocardiographic strain are reported in
Table 10. Pooled data (though heavily weighted by a single vendor)
suggest that global longitudinal RV free wall strain > 20% (i.e.,
<20% in absolute value) is likely abnormal.
Recommendations. Two-dimensional STE-derived strain, particu-
larly of the RV free wall, appears to be reproducible and feasible for
clinical use. Because of the need for additional normative data from
large studies involving multivendor equipment, no definite reference
ranges are currently recommended for either global or regional RV
strain or strain rate.
8.6. RV 3D EF. Three-dimensional echocardiographic RV EF is a
global measure of RV systolic performance. Although RV EF does
not directly reflect RV contractile function per se, it provides an inte-
grated view of the interaction between RV contractility and load. RV
EF can be of particular clinical value in patients after cardiac surgery
(in the absence of marked septal shift), when conventional indices
of longitudinal RV function (i.e., TAPSE, S0 wave) are generally
reduced and no longer representative of overall RV perfor-
mance.81,89,90 Three-dimensional echocardiography has been exten-
sively validated against CMR,78,91 and the volumetric semiautomated
border detection approach is the recommended method for the
assessment of RV EF.
The limitations of 3D assessment of RV EF are load dependency,
interventricular changes affecting septal motion, poor acoustic win-
dows, and irregular rhythms. As described above in the section on
RV volume, the RV EF is slightly higher in women than in men,
because of smaller volumes, and it is recommended to refer to
gender-specific values (Supplemental Table 8).
Recommendation. In laboratories with appropriate 3D platforms
and experience, 3DE-derived RV EF should be considered as a
method of quantifying RV systolic function, with the limitations
mentioned above. Roughly, an RV EF of <45% usually reflects
abnormal RV systolic function, though laboratories may choose to
refer to age- and gender-specific values.III. THE LEFT AND RIGHT ATRIA
The left atrium fulfills three major physiologic roles that influence LV
filling and performance. The left atrium acts as a (1) contractile pump
Table 9 Recommendations for the echocardiographic assessment of RV function
Echocardiographic imaging Recommended methods Advantages Limitations
RV global function
Pulsed Doppler RIMP RIMP (Tei index) by pulsed
Doppler:
RIMP = (TCO  ET)/ET
 Prognostic value
 Less affected by heart rate
 Requires matching for R-R
intervals when measure-
ments are performed on
separate recordings
 Unreliable when RA pres-
sure is elevated
Tissue Doppler RIMP RIMP by tissue Doppler:
RIMP = (IVRT + IVCT)/ET =
(TCO  ET)/ET
 Less affected by heart rate
 Single-beat recording with
no need for R-R interval
matching
 Unreliable when RA pres-
sure is elevated
RV global systolic function
FAC
EF
RV FAC in RV-focused
apical four-chamber view:
RV FAC (%) = 100  (EDA 
ESA)/EDA
Fractional RV volume
change by 3D TTE:
RV EF (%) = 100  (EDV 
ESV)/EDV
 Established prognostic
value
 Reflects both longitudinal
and radial components of
RV contraction
 Correlates with RV EF by
CMR
 Includes RV outflow tract
contribution to overall func-
tion
 Correlates with RV EF by
CMR
 Neglects the contribution of
RV outflow tract to overall
systolic function
 Only fair inter-observer
reproducibility
 Dependent on adequate
image quality
 Load dependency
 Requires offline analysis and
experience
 Prognostic value not estab-
lished
(Continued )
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Table 9 (Continued )
Echocardiographic imaging Recommended methods Advantages Limitations
RV longitudinal systolic function
TAPSE
Pulsed tissue Doppler S wave
Color tissue Doppler S wave
GLS
 Tricuspid annular longitudi-
nal excursion by M-mode
(mm), measured between
end-diastole and peak sys-
tole
 Proper alignment of M-
mode cursor with the direc-
tion of RV longitudinal
excursion should be
achieved from the apical
approach.
 Peak systolic velocity of
tricuspid annulus by pulsed-
wave DTI (cm/sec), obtained
from the apical approach, in
the view that achieves par-
allel alignment of Doppler
beam with RV free wall lon-
gitudinal excursion
 Peak systolic velocity of
tricuspid annulus by color
DTI (cm/sec)
 Peak value of 2D longitudi-
nal speckle tracking derived
strain, averaged over the
three segments of the RV
free wall in RV-focused api-
cal four-chamber view (%)
 Established prognostic
value
 Validated against radionu-
clide EF
 Easy to perform
 Reproducible
 Validated against radionu-
clide EF
 Established prognostic
value
 Sampling is performed after
image acquisition
 Allows multisite sampling on
the same beat
 Angle independent
 Established prognostic
value
 Angle dependency
 Partially representative of
RV global function*
 Angle dependent
 Not fully representative of
RV global function, particu-
larly after thoracotomy,
pulmonary thromboendar-
terectomy or heart
transplantation
 Angle dependent
 Not fully representative of
RV global function, particu-
larly after thoracotomy,
pulmonary thrombendarter-
ectomy or heart
transplantation
 Lower absolute values and
reference ranges than
pulsed DTI S0 wave
 Requires offline analysis
 Vendor dependent
EDA, End-diastolic area; ESA, end-systolic area; ET, ejection time;GLS, gold longitudinal strain; IVCT, isovolumic contraction time; TCO, tricuspid
valve closure–to–opening time.
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Table 10 Normal values for parameters of RV function
Parameter Mean 6 SD Abnormality threshold
TAPSE (mm) 24 6 3.5 <17
Pulsed Doppler S wave (cm/sec) 14.1 6 2.3 <9.5
Color Doppler S wave (cm/sec) 9.7 6 1.85 <6.0
RV fractional area change (%) 49 6 7 <35
RV free wall 2D strain* (%) 29 6 4.5 >20 (<20 in magnitude with the
negative sign)
RV 3D EF (%) 58 6 6.5 <45
Pulsed Doppler MPI 0.26 6 0.085 >0.43
Tissue Doppler MPI 0.38 6 0.08 >0.54
E wave deceleration time (msec) 180 6 31 <119 or >242
E/A 1.4 6 0.3 <0.8 or >2.0
e0/a0 1.18 6 0.33 <0.52
e0 14.0 6 3.1 <7.8
E/e0 4.0 6 1.0 >6.0
MPI, Myocardial performance index.
*Limited data; values may vary depending on vendor and software version.
Figure 7 (A) Three apical images demonstrating different views of the right ventricle (RV). The middle image shows the right ventric-
ular–focused view. (B) The rationale for maximizing the right ventricular basal dimension in the right ventricular–focused view. Below
the cartoon, by manipulating offline the same 3D right ventricular data set, it is apparent that minor variations in the four-chamber
plane position (dashed line) with respect to the right ventricular crescent shape may result in variability of right ventricular size
when performed by linear measurements.
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Figure 9 Measurement of RV systolic strain by 2D STE. The upper panel demonstrates RV ‘‘global’’ free wall strain whereby the three
segments of the freewall are averaged, and the lower panel demonstrates ‘‘global’’ longitudinal strain of the six segments of the apical
four-chamber view: three free wall and three septal segments. Note that RV longitudinal strain is significantly higher (as an absolute
value) than the strain averaged from both septal and free wall segments. Until a universal standard is established, the interpretation of
RV longitudinal strain values should take into account the methodology and vendor- and method-specific reference values.
Figure 8 Three-dimensional analysis of the right ventricle (RV). (A) A 3D data set is acquired from a right ventricular–focused apical
four-chamber view by stitching together the subvolumes generated from several (four to six) consecutive beats. (B) The right ventric-
ular endocardial surface is semiautomatically identified after manual initialization in the right ventricular short-axis, four-chamber, and
coronal views in both end-systole and end-diastole. (C) The generated 3D surface model of the RV enables the quantitation of right
ventricular ESV and ESV, stroke volume, and EF.
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January 2015that delivers 15% to 30% of the entire LV filling, (2) reservoir that col-
lects pulmonary venous return during ventricular systole, and (3)
conduit for the passage of stored blood from the left atrium to the
left ventricle during early ventricular diastole.92,93 An enlarged left
atrium is associated with adverse cardiovascular outcomes.94-99 In
the absence of mitral valve disease, an increase in LA size most
commonly reflects increased wall tension as a result of increased
LA pressure,100-103 as well as impairment in LA function secondary
to an atrial myopathy.104,105 A clear relationship exists between
an enlarged left atrium and the incidence of atrial fibrillation
and stroke,92,106-115 risk for overall mortality after myocardialinfarction,104,105,116,117 risk for death and hospitalization in patients
with dilated cardiomyopathy,118-122 and major cardiac events or
death in patients with diabetes mellitus.123 LA enlargement is a
marker of both the severity and chronicity of diastolic dysfunction
and magnitude of LA pressure elevation.98,100-1039. LA Measurements
9.1. General Considerations for LA Size. TTE is the recommen-
ded approach for assessing LA size. Recommendations for LA
Journal of the American Society of Echocardiography
Volume 28 Number 1
Lang et al 25quantification are summarized in Table 11. With TEE, the entire left
atrium frequently cannot be fit in the image sector. Accordingly,
TEE should not be used to assess LA size. LA size should be measured
at the end of LV systole, when the LA chamber is at its greatest dimen-
sion. While acquiring images to measure LA size and volumes, care
should be taken to avoid foreshortening of the left atrium. Because
the longitudinal axes of the left ventricle and left atrium frequently
lie in different planes, dedicated acquisitions of the left atrium from
the apical approach should be obtained for optimal LA volume mea-
surements. The base of the left atrium should be at its largest size, indi-
cating that the imaging plane passes through the maximal short-axis
area. LA length should also be maximized to ensure alignment along
the true long axis of the left atrium. When using the biplane disk sum-
mation method to calculate LA volumes, the lengths of the long axes
measured in the two- and four-chamber views should be similar.
When tracing the borders of the left atrium, the confluences of the
pulmonary veins and the LA appendage should be excluded. The
atrioventricular interface should be represented by the mitral annulus
plane, not by the tip of the mitral leaflets.
9.2. Linear Dimensions and Area Measurements. The most
widely used linear dimension is the LA anteroposterior (AP) measure-
ment in the parasternal long-axis view using M-mode echocardiogra-
phy or, preferably, 2DE.92,107,109,110,114,118,120,121,124,125 Although this
measurement has been used extensively in clinical practice and
research, it has become clear that frequently it may not represent an
accurate picture of LA size.126,127 Traditionally, the AP dimension
was widely used because it was known to be the most reproducible
measurement. However, assessment of LA size using only the AP
diameter assumes that when the left atrium enlarges, all its
dimensions change similarly, which is often not the case during LA
remodeling.128-130 Therefore, AP linear dimension should not be
used as the sole measure of LA size. LA area can be planimetered in
the apical four- and two-chamber views and normal values for these
parameters have been reported.12 Optimal contours should be ob-
tained orthogonally around the long axis of the left atrium from
good quality images while avoiding foreshortening.1 The ease with
which LA volumes can be obtained in clinical practice in conjunction
with the existing robust literature on normal values and the prognostic
value of LA volumes renders reporting of LA area unnecessary.
9.3. Volume Measurements. When assessing the LA size and re-
modeling, the measurement of LA volume is recommended.
Evaluation of volume takes into account alterations in LA chamber
size in all directions. LA volume has been shown to be a powerful
prognostic variable in a variety of cardiac disease
states.99,106,112,113,115-117,122,131-136 Compared with AP diameter, LA
volume has a stronger association with outcomes in cardiac
patients.113,137 Two-dimensional echocardiographic LA volumes are
typically smaller than those reported from computed tomography
or CMR.138-142 Measurements of LA volumes are important,
because they reflect the burden and chronicity of elevated LV filling
pressures and are a strong predictor of outcomes.
Different methods exist for measuring LA volumes. Although the
three linearmeasurements have been used to calculate LAvolume us-
ing an ellipsoid model,131,137,143 the relative inaccuracy of these linear
measurements limits this method. LA volume should be measured
using the disk summation algorithm, similar to that used to measure
LV volume (Table 11).144,145
The LA endocardial borders should be traced in both the apical
four- and two-chamber views. A single-plane approach can also beused, but this method is based on the geometric assumption that
the left atrium is circular in the short-axis cut plane, which may not
be always accurate.146 Although not recommended for routine use,
this approach could be used in cases when planimetry in both views
is difficult. Single-plane apical four-chamber indexed LA volumes are
typically 1 to 2 mL/m2 smaller than apical two-chamber vol-
umes.12,146
Alternatively, a biplane calculation could also be performed using
the LA areas and lengths measured from both the apical four- and
two-chamber views (Table 11). Although the area-length method still
assumes an ellipsoidal LA shape, it has the advantage of reducing
linear dimensions to only twomeasurements of atrial length, of which
the shorter one is selected.98,147
9.4. Normal Values of LAMeasurements. Since the publication
of the 2005 chamber quantification guidelines, two articles have re-
ported normal values for LA linear measurements.12,143 These
values were in keeping with prior recommendations, and
accordingly, no modifications have been made to the normal values
of LA AP diameters (Supplemental Table 9). Although not recom-
mended for routine clinical use, normal values for apical four- and
two-chamber linear measurements and nonindexed LA area and vol-
ume measurements have been reported.12
LA size is dependent on gender. However the gender differences in
LA size are generally accounted for when adjusting for body size.12
Several indexing methods have been proposed,137,148 but indexing
to BSA has yielded the most available data and is recommended by
the writing group. Indexing by BSA accounts for the gender
differences in LA size, such that only the indexed value should be
reported.93,137,149,150
In the prior chamber quantification guideline document, the re-
ported BSA-indexed LA volume normal values were based on two
studies performed in a small number of subjects.98,144 Since the
publication of that document, eight additional studies (1,234
patients) describing normal values of LA volumes using the area-
length ellipsoid or the disk summation techniques have been
reported.11,12,145,147,151-155 This has resulted in a change in the
recommended upper normal indexed LA volume to 34 mL/m2
(previously 28 mL/m2). In addition, LA volume data became
available in 1,331 patients from the five databases described earlier
in this document, wherein the mean calculated LA volume was
25 mL/m2. This upper normal revised value of 34 mL/m2 also
seems to fit inwell with a risk-based approach for determination of cut-
offs between a normal and an enlarged left atrium.106,123,134,136 This
cutoff value is also consistent with the ASE and European
Association of Echocardiography guideline document on evaluation
of diastolic function.156 The 2DE-derived biplane LA volumes are
listed in Table 4, including normal ranges and severity partition cutoffs.
Of note, LA volume can be increased in elite athletes, which needs to
be taken into account to avoid misinterpretation as abnormal.146
Three-dimensional echocardiography holds promise for assessing
LA volume and correlates with cardiac computed tomogra-
phy157,158 and magnetic resonance imaging.159,160 Compared with
2D assessment of LA volume, 3DE is more accurate compared
with CMR159,160 and has superior prognostic ability.161,162 Three-
dimensional echocardiographic LA volumes are typically larger
than 2D echocardiographic volumes in most studies.160,163
Despite these advantages, the lack of a standardized methodology
and limited normative data164 prevent this committee from recom-
mending the use of 3D echocardiographic normal values at this
time.
Table 11 Recommendations for the echocardiographic assessment of LA size
Parameter and method Echocardiographic imaging Advantages Limitations
Internal linear
dimensions.
The anteroposterior
diameter of the left atrium
can be measured in the
parasternal long-axis view
perpendicular to the aortic
root long axis, and
measured at the level of the
aortic sinuses by using the
leading-edge to leading-
edge convention.
M-mode tracing
2D-guided linear measurements
 Reproducible
 High temporal resolution
 Wealth of published data
 Facilitates orientation
perpendicular to LA
posterior wall
Single dimension not rep-
resentative of actual LA
size (particularly in dilated
atria)
 Lower frame rates than in
M-mode
 Single dimension only
Area.
Measured in four-chamber
apical view, at end-systole,
on the frame just prior to
mitral valve opening by
tracing the LA inner border,
excluding the area under
the mitral valve annulus
and the inlet of the
pulmonary veins.
2D images  More representative of
actual LA size than ante-
roposterior diameter only
 Need for a dedicated
view to avoid LA fore-
shortening
 Assumes a symmetric
shape of the atrium
(Continued )
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Table 11 (Continued )
Parameter and method Echocardiographic imaging Advantages Limitations
Volume.
2D volumetric
measurements are based
on tracings of the blood-
tissue interface on apical
four- and two-chamber
views. At the mitral valve
level, the contour is closed
by connecting the two
opposite sections of the
mitral annulus with a
straight line. Endocardial
tracing should exclude
atrial appendage and
pulmonary veins. LA length
L is defined as the shortest
of the two long axes
measured in the apical
two- and four-chamber
views (to provide reliable
calculations the two
lengths should not differ
more than 5 mm). Volumes
can be computed by using
the area-length
approximation:
8
3p

ðA1$A2Þ
L

where A1 and A2 are the
corresponding LA areas.
Alternatively LA volume
can be calculated using the
disk summation technique
by adding the volume of a
stack of cylinders of height
h and area calculated by
orthogonal minor and
major transverse axes (D1
and D2) assuming an oval
shape:
p=4ðhÞPðD1ÞðD2Þ
3D data sets are usually
obtained from the apical
approach using a multibeat
full-volume acquisition
2DE
Area-length technique
Biplane method of disks
3D data sets
 Enables accurate
assessment of the
asymmetric remodeling
of the left atrium
 More robust predictor of
cardiovascular events
than linear or area mea-
surements
 No geometrical assump-
tion about LA shape
 More accurate when
compared to 2D mea-
surements
 Geometric assumptions
about LA shape
 Few accumulated data
on normal population
 Single plane volume cal-
culations are inaccurate
since they are based on
the assumption that A1 =
A2
 Dependent on adequate
image quality
 Lower temporal resolu-
tion
 Limited data on normal
values
 Patient’s cooperation
required
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the area-length method, the biplane disk summation technique,
which incorporates fewer geometric assumptions, should be the
preferred method to measure LA volume in clinical practice. The up-
per normal limit for 2D echocardiographic LA volume is 34 mL/m2
for both genders.
10. Right Atrial measurements
Less research and fewer clinical outcomes data are available on the
quantification of RA size. Although the right atrium can be assessed
from different views, quantification of RA size is most commonly per-
formed from the apical four-chamber view (Table 12). The minor-axis
dimension should be taken from a plane perpendicular to the long
axis of the right atrium, extending from the lateral border of the right
atrium to the interatrial septum. In contrast to the left atrium, RA size
appears to be gender dependent, but prior ASE guidelines did not
have sufficient data to provide normative data by gender.1,71
Recent data obtained from three cohorts of >2,400 patients now
provide normal values of RA dimensions for men and
women.12,73,165
As with the left atrium, RA volumes are likely to be more robust
and accurate for determination of RA size compared with linear di-
mensions. At the time of the prior guideline document, limited data
were available for the determination of normative RA volumes.
Because there are no standard orthogonal RA views to use for an
apical biplane calculation, a single-view area-length and/or disk
summation techniques has been proposed for RA volume
determination.150,153,165-167 Of note, normal RA volumes for men
are slightly larger than those for women, with indexing to BSA
failing to equalize values between genders for reasons that are not
fully understood.150,165 Recommendations for RA volume
normative data are made from the two largest most contemporary
data sets12,165 (Table 13). RA volumes are underestimated with 2D
echocardiographic techniques compared with 3DE.164,165,168 RA
volumes in adult subjects appear to be smaller than LA
volumes.12,150,153,165 This is because the RA volumes were obtained
using a single-plane method of disks, in contrast to the LA volumes,
which were established using the biplane technique.
Recommendations. The recommended parameter to assess RA
size is RA volume, calculated using single-plane area-length or disk
summation techniques in a dedicated apical four-chamber view.
The normal ranges for 2D echocardiographic RA volume are
25 6 7 mL/m2 in men and 21 6 6 mL/m2 in women.IV. THE AORTIC ANNULUS AND AORTIC ROOT
Detailed knowledge and quantification of the aortic root and aortic
valve morphology has become even more crucial with the increasing
use of transcatheter aortic valve implantation (TAVI) and transcath-
eter aortic valve replacement (TAVR) procedures. This knowledge is
critically important for preprocedural planning, intraprocedural guid-
ance, and postprocedural assessment.
The aortic root extends from the basal attachments of the aortic
valve leaflets within the LV outflow tract to their distal attachment
at the tubular portion of the aorta (the sinotubular junction).169 The
aortic root is a geometrically complex structure that includes (1) the
aortic valve annulus, (2) the interleaflet triangles, (3) the semilunaraortic leaflets and their attachments, (4) the aortic sinuses of
Valsalva, and (5) the sinotubular junction.170-172 Aortic
measurements should be made at the following sites: (1) the aortic
valve annulus, (2) the maximal diameter of the sinuses of Valsalva,
(3) the sinotubular junction (usually a demarcated transition
between the sinuses of Valsalva and the tubular portion of the
ascending aorta), and (4) the maximal diameter of the proximal
ascending aorta, including a notation of the distance between the
measurement site and the sinotubular junction (Figure 10A).11. The Aortic Annulus
The ‘‘aortic annulus’’ is not a true or distinct anatomic structure but is a
virtual ring that may be defined by joining the basal attachments, or
nadirs, of the three aortic leaflets. The distal (uppermost) attachments
of the leaflets, in the shape of a crown, form a true anatomic
ring169,173 (Figure 10B). Approximately two-thirds of the circumfer-
ence of the lower part of the aortic root is attached to the muscular
interventricular septum, while the remaining one-third is in fibrous
continuity with the anterior mitral valve leaflet.174 Measurement of
the aortic valve annulus before TAVI or TAVR is a challenge, and
the ideal modality for its measurement has yet to be established.
During the initial TAVI and TAVR experience, aortic annular measure-
ments were routinely performed using 2DE.174,175 Although the
standard approach during the early years of TAVI and TAVR was
echocardiography using a one-dimensional measurement, this
method has clear limitations for TAVI and TAVR valve sizing. At pre-
sent, the two most commonly used imaging techniques used for
measuring the aortic annulus before TAVI or TAVR are echocardiog-
raphy and multidetector computed tomography (MDCT).
With echocardiography, measurements of the aortic annulus
should be made in the zoom mode using standard electronic calipers
in midsystole, when the annulus is slightly larger and rounder than in
diastole, between the hinge points of the aortic valve leaflets (usually
between the hinge point of the right coronary cusp and the edge of
the sinus at the side of the commissures between the left coronary
cusp and the noncoronary cusp) from inner edge to inner edge. All
other aortic measurements should be made at end-diastole, in a
strictly perpendicular plane to that of the long axis of the aorta.
Aortic annular measurements may be difficult in patients with acous-
tic blooming caused by a calcified aortic annulus.176-179 As a general
rule, calcium protuberances should be considered as part of the
lumen, not of the aortic wall, and therefore excluded from the
diameter measurement.
The anteroposterior diameter is commonly measured by both 2D
TTE (from the parasternal long-axis view) and 3D TEE (from the lon-
gitudinal view of the proximal aortic root, usually 110–130) and ap-
proximates the minor dimension of the annulus measured by
MDCT.3,176,180 However, because the annulus is often elliptical,
with variable diameters, it is preferable to measure the annulus in a
cross-sectional view, using 3D imaging, as recommended by the
European Association of Echocardiography and ASE guidelines181;
the American College of Cardiology Foundation, American
Association for Thoracic Surgery, Society for Cardiac Angiography
and Interventions, and Society of Thoracic Surgeons consensus docu-
ment on TAVR182; the Society of Cardiovascular Computed
Tomography expert consensus document on MDCT183; and
others.184-187 Using 3D TEE, both the smaller (anteroposterior,
sagittal) and larger (medial-lateral, coronal) diameters, as well as the
perimeter and annular area, should be measured in a cross-sectional
Table 12 Recommendations for the echocardiographic assessment of RA size
Parameter and method Echocardiographic imaging Advantages Limitations
Linear dimensions.
The minor axis of the right atrium
should be measured in the apical
four-chamber view as the
distance between the lateral RA
wall and interatrial septum, at the
midatrial level defined by half of
RA long axis
2D-guided linear measurements  Easy to obtain
 Established normal values
 Single dimension only
 Assumes that RA enlargement
is symmetrical
 View dependent
Area.
Measured in the apical four-
chamber view at end-systole, on
the frame just prior to tricuspid
valve opening, by tracing the RA
blood-tissue interface, excluding
the area under the tricuspid valve
annulus.
2D view  More representative of actual
RA size than linear dimensions
 Established normal values
 Need of a dedicated view to
avoid RA foreshortening
 Assumes a symmetrical shape
of the cavity
 View dependent
Volume.
2D volumetric measurements are
usually based on tracings of the
blood-tissue interface on the
apical four-chamber view. At the
tricuspid valve level, the contour is
closed by connecting the two
opposite sections of the tricuspid
ring with a straight line. Volumes
can be computed by using either
the single plane area-length:
8
3p
"
ðAÞ2
L
#
or the disks summation technique.
3D data sets are usually obtained
from the apical approach using a
full-volume acquisition
2D view
3D data sets
 More representative of actual
RA size than linear dimensions
 No geometrical assumption
 Established normal values
 Assumes a symmetrical shape
of the cavity
 Single plane volume calculation
may be inaccurate since it as-
sumes that RA enlargement is
symmetrical
 Normal values not well estab-
lished
 Dependent on image quality
 Lower temporal resolution
 Patient’s cooperation required
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Table 13 Normal RA size obtained from 2D
echocardiographic studies
Women Men
RA minor axis dimension (cm/m2) 1.9 6 0.3 1.9 6 0.3
RA major axis dimension (cm/m2) 2.5 6 0.3 2.4 6 0.3
2D echocardiographic RA volume (mL/m2) 21 6 6 25 6 7
Data are expressed as mean 6 SD.
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between major and minor diameters may be up to 6 mm.173,188-193
For a detailed, step-by-step approach to making these measurements
using 3DTEE, which is beyond the scope of this document, the reader
is referred to four recent publications.184-187 By using these
techniques, close agreement with MDCT can be achieved.184,185
It should be noted that proponents of each of the two modalities
(3D TEE and MDCT) tout advantages. In fact, each of these
methods has certain strengths and limitations. Limitations of
MDCT include the need for contrast media, radiation exposure,
inability to obtain real-time measurements during the procedure,
and the need to control the heart rate for suitable gating. Three-
dimensional TEE also has limitations. First, the software required
to use the methodology described by Kasel et al.184 and Pershad
et al.185 is not currently available on all echocardiographic platforms.
Second, visualization of the anterior portion of the annulus can be
obscured by echo ‘‘dropout’’ due to annular calcification. In addition,
calcification at the level of the annulus may hinder the ability to
determine boundary definition and may make its shape irregular.
Third, the plane formed by the nadirs of the three cusps is often
not orthogonal to the LV outflow tract or aortic root; frequently
the insertion of the right coronary cusp is inferior to that of the
left and noncoronary cusps.183 Fourth, both the spatial and temporal
resolution of 3D echocardiography is currently limited. Last, this
technique is operator dependent and may be difficult at times,
even in experienced hands.173,174 Because of these potential
limitations, it is desirable to use a multimodality approach for
aortic annular measurement.Figure 10 (A) Sites for measurements of the aortic root and
ascending aorta. This diagram illustrates the four sites at which
measurements are recommended (light blue arrows): (1) the aortic
valve annulus (hinge point of aortic leaflets), (2) the sinuses of
Valsalva (maximal diameter, usually themidpoint), (3) the sinotub-
ular junction, and (4) the proximal ascending aorta (the distance
between the measurement site and the annular plane [purple ar-
rowheads] should always be reported). The aortic annulus should
bemeasured at peak systole, in contrast to the other dimensions,
which are measured at end-diastole. The dashed lines, depicting
the longitudinal axis of the left ventricle (LV) and that of the aortic
root and proximal ascending aorta, are different. Note that the
angle between these two axes varies from individual to individual
and with age and pathology. (B) Normal anatomy of the aortic
annulus. The aortic annulus accounts for the tightest part of the
aortic root and is defined as a virtual ring (shaded) with three
anatomic anchor points at the nadir of each of the attachments
of the three aortic leaflets. Reproduced with permission from
Kasel et al.184 Ao, Aorta; LA, left atrium.12. The Aortic Root
With 2D TTE, the diameter of the aortic root (at the maximal diam-
eter of the sinuses of Valsalva) should be obtained from the paraster-
nal long-axis view, which depicts the aortic root and the proximal
ascending aorta. This plane is slightly different from that of the long
axis of the left ventricle (Figure 10A). Acquisition of this LV long-
axis view may be performed from different intercostal spaces and
at various distances from the left sternal border. Use of simultaneous
biplane orthogonal images provided by matrix transducers may be
helpful. The tubular ascending aorta is often not adequately visualized
from a standard parasternal window. In these instances, moving the
transducer closer to the sternum may allow visualization of a longer
portion of the ascending aorta. In addition, the ascending aorta may
sometimes be well visualized from right parasternal windows in the
second or third intercostal space, especially when the aorta is dilated.
Measurements should be made in the view that depicts the
maximum aortic diameter perpendicular to the long axis of the aorta.
In patients with tricuspid aortic valves, the closure line of the leaflets
(typically the right coronary cusp and the noncoronary cusp) is in the
center of the aortic root lumen, and the closed leaflets are seen on the
aortic side of a line connecting the hinge points of the two visualized
leaflets. An asymmetric closure line, in which the tips of the closed
leaflets are closer to one of the hinge points, is an indication that
the cross-section is not encompassing the largest root diameter
(Figure 12).
Unfortunately, there is no uniform method of measurement of the
aortic root and aorta. Echocardiography uses the leading edge–to–
leading edge (L-L) convention, but other techniques, such as
MDCT and CMR, use the inner edge–to–inner edge (I-I) or outer
edge–to–outer edge convention. In the consensus document,194
the ASE and EACVI writing committee took the initiative to providea common standard for measurement of the aortic root and aorta by
recommending a switch to the I-I convention for echocardiography.
However, this goal of achieving uniformity among modalities was ul-
timately abandoned for several reasons. First, currently used long-
standing reference values for the aorta were obtained using the L-L
convention.195,196 Second, the L-L convention provides statistically
Figure 11 The smaller (antero-posterior, sagittal) aortic root diameter is measured using CT (A) or 3D TEE (C, zoomed cross sectional
view) between the inner edges of the left (L) and non-coronary (NC) commissure to the opposite right (R) coronary sinus (A and C,
yellow double arrows). The larger diameter (medial-lateral) is measured from the middle of the right sinus to the most distal point
of the NC sinus (A and C, purple double arrows). Panel B shows zoomed cross-sectional CT views of aortic root at the sinus of
Valsalva level using a double oblique image for orientation. Panel D shows a long-axis view of the aorta in obtained by multiplanar
reconstruction. The red lines in (B) and (D) represent the planes from which the diameter of the aortic root should be measured at
the level of the sinuses of Valsalva.
Figure 12 Correct (A) and incorrect (B, C)measurements of the aortic annulus (double arrows). (A)Centrally positioned diameter and
central closure of leaflets. Thin lines correspond to the long axis of the ascending aorta and, orthogonally, to correct orientation of the
annular diameter. (B) Incorrect, eccentric annular measurement. The hinge points are slightly displaced upward and do not corre-
spond to the nadir of the cusp attachments, with incomplete opening and closing of leaflets. (C) Incorrect, oblique annular measure-
ment. The annulus is ‘‘virtual’’ and only defined by the hinge-points of the three aortic valve leaflets. As such, much of the ring is
without a visible anatomic structure. However, its location on any long-axis two-dimensional view can be approximated since the
plane of the virtual annulus is approximately perpendicular to the long-axis of the aorta. When bisecting the maximum dimension
of the annulus in the sagittal plane, one will image the right coronary cusp anteriorly and the fibrous trigone between the left and
noncoronary cusps posteriorly. Because only one anatomic marker (the RCC hinge-point) is seen, the opposing annulus must be
approximated with a measurement that is perpendicular to the long axis of the aorta. Attempting to measure what you believe to
be 2 hinge-points (B and C) typically will measure within the sinuses of Valsalva and overestimate the annulus.
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to the I-I convention raised a concern that patients at potential risk for
developing life-threatening complications such as aortic dissection
and/or rupture would fall below a threshold for intervention recom-
mendation by current guidelines. Accordingly, the aortic annulus
should be measured using the I-I convention, but we continue torecommend the L-L convention for measurements of the aortic
root and aorta.
Two-dimensional echocardiographic aortic diameter measure-
ments are preferable to M-mode measurements, because cardiac mo-
tion may result in changes in the position of the M-mode cursor
relative to the maximum diameter of the sinuses of Valsalva. This
Figure 13 The 95% confidence intervals for aortic root diameter at sinuses of Valsalva on the basis of BSA in children and adoles-
cents (A), adults aged 20 to 39 years (B), and adults aged $40 years (C). Reprinted with permission from Roman et al.195
Table 14 Aortic root dimensions in normal adults
Aortic Root
Absolute values (cm) Indexed values (cm/m2)
Men Women Men Women
Annulus 2.6 6 0.3 2.3 6 0.2 1.3 6 0.1 1.3 6 0.1
Sinuses of Valsalva 3.4 6 0.3 3.0 6 0.3 1.7 6 0.2 1.8 6 0.2
Sinotubular junction 2.9 6 0.3 2.6 6 0.3 1.5 6 0.2 1.5 6 0.2
Proximal ascending aorta 3.0 6 0.4 2.7 6 0.4 1.5 6 0.2 1.6 6 0.3
Adapted from Roman et al.195 and Hiratzka et al.204
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approximately 2 mm) of the aortic diameter by M-mode imaging in
comparison with 2D echocardiographic measurements.195 The
thoracic aorta can be better imaged using TEE compared with the
TTE approach, because that aortic segment is in the near field of
the transesophageal echocardiographic transducer. The aortic root
and ascending aorta can be best seen in the midesophageal aortic
valve long-axis view (three-chamber view at about 120–140).3
The short-axis view of the ascending aorta is best obtained using
the midesophageal views at about 45. For measurements of the de-
scending aorta, short-axis views at about 0 and long-axis views at
about 90 should be obtained from the level of the diaphragm up
to the aortic arch. The biplane imaging function on current 3D echo-
cardiographic imaging systems allows simultaneous visualization of
both short- and long-axis views.13. Identification of Aortic Root Dilatation
Aortic root dilatation is associated with the presence and progression
of aortic regurgitation197 and with the occurrence of aortic dissection.
The presence of hypertension appears to have minimal impact on
aortic root diameter at the level of the sinuses of Valsalva level197
but is associated with enlargement of more distal aortic segments.
Aortic root diameter measurements at the level of the sinuses of
Valsalva is closely related to BSA and age. Therefore, BSA may be
used to predict aortic root diameter in three age strata, <20, 20 to
40, and >40 years, by using published equations.195 Aortic root dila-
tation at the sinuses of Valsalva is defined as an aortic root diameter
above the upper limit of the 95% confidence interval of the distribu-tion in a large reference population. Aortic dilatation can be easily de-
tected by plotting observed aortic root diameter versus BSA on
previously published nomograms (Figure 13).195 Equations to deter-
mine the expected aortic diameter at the sinuses of Valsalva in relation
to BSA for each of the three age strata are also shown in Table 14 and
Figure 13. The aortic root index or ratio of observed to expected
aortic root diameters can be calculated by dividing the observed by
the expected diameter.
Recommendations. The aortic annulus should be measured at
midsystole from inner edge to inner edge. All other aortic root mea-
surements (i.e., maximal diameter of the sinuses of Valsalva, the sino-
tubular junction, and the proximal ascending aorta) should be made
at end-diastole, in a strictly perpendicular plane to that of the long axis
of the aorta using the L-L convention. Measurements of maximal
diameter of the aortic root at the sinuses of Valsalva should be
compared with age- and BSA-related nomograms or to values calcu-
lated from specific allometric equations. Accurate measurement of
the aortic annulus before TAVI or TAVR is crucial. To date, there is
no established gold-standard technique for measuring the aortic
annulus before TAVI or TAVR. Three-dimensional TEE and MDCT
are emerging as reliable and possibly preferred methods for aortic
annulus measurements.V. THE INFERIOR VENA CAVA
Examination of the IVC from the subcostal view should be included
as part of the routine transthoracic echocardiographic examination. It
Journal of the American Society of Echocardiography
Volume 28 Number 1
Lang et al 33is generally agreed that the diameter of the IVC should be measured
in the subcostal view with the patient in the supine position at 1.0 to
2.0 cm from the junction with the right atrium, using the long-axis
view. For accuracy, this measurement should be made perpendicular
to the IVC long axis. The diameter of the IVC decreases in response to
inspiration when the negative intrathoracic pressure leads to an
increase in RV filling from the systemic veins. The diameter of the
IVC and the percentage decrease in the diameter during inspiration
correlate with RA pressure. The relationship may be quantified as
the collapsibility index.198 Evaluation of the inspiratory response
often requires a brief sniff, as normal inspiration may not elicit this
response.
For simplicity and uniformity of reporting, specific values of RA
pressure, rather than ranges, should be used in the determination of
systolic pulmonary artery pressure. IVC diameter < 2.1 cm that col-
lapses >50% with a sniff suggests normal RA pressure of 3 mm Hg
(range, 0–5 mm Hg), whereas IVC diameter > 2.1 cm that col-
lapses < 50% with a sniff suggests high RA pressure of 15 mm Hg
(range, 10–20 mm Hg).199 In scenarios in which IVC diameter and
collapse do not fit this paradigm, an intermediate value of 8 mm
Hg (range, 5–10 mm Hg) may be used, or, preferably, other indices
of RA pressure should be integrated to downgrade or upgrade to
the normal or high values of RA pressure. It should be noted that in
normal young athletes, the IVC may be dilated in the presence of
normal pressure.200,201 In addition, the IVC is commonly dilated
and may not collapse in patients on ventilators, so it should not be
routinely used in such cases to estimate RA pressure.202 However,
IVC diameter measured on TEE at the cavoatrial junction has been
successfully used to derive central venous pressure in anesthetized
mechanically ventilated patients.203 The use of the IVC size and dy-
namics is encouraged for estimation of RA pressure. This estimate
should be used in estimation of the pulmonary artery pressure on
the basis of the tricuspid regurgitant jet velocity, rather than assuming
a constant RA pressure for all patients.NOTICE AND DISCLAIMER
This report is made available by the ASE and EACVI as a courtesy
reference source for members. This report contains recommenda-
tions only and should not be used as the sole basis to make medical
practice decisions or for disciplinary action against any employee.
The statements and recommendations contained in this report are
based primarily on the opinions of experts, rather than on scientifi-
cally verified data. The ASE and EACVI make no express or implied
warranties regarding the completeness or accuracy of the information
in this report, including the warranty of merchantability or fitness for a
particular purpose. In no event shall the ASE and EACVI be liable to
you, your patients, or any other third parties for any decision made or
action taken by you or such other parties in reliance on this informa-
tion. Nor does your use of this information constitute the offering of
medical advice by the ASE and EACVI or create any physician-patient
relationship between the ASE and EACVI and your patients or
anyone else.REFERENCES
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When possible, data on systolic blood pressure, diastolic blood pres-
sure, diagnosis of hypertension, treatment of hypertension, diagnosis
of diabetes, fasting glucose levels, creatinine levels, total cholesterol
level, low-density lipoprotein cholesterol levels, and triglyceride levels
were obtained. BSA was calculated using the Mosteller formula.205
Body mass index was calculated by dividing the weight in kilograms
by the height in meters squared.Echocardiographic Measurements
Transthoracic echocardiographic measurements were performed for
each of the studies as per available published guidelines.1 Values for
the following measurements were provided from the following 2Dtransthoracic echocardiographic views: LV end-diastolic diameter
and LV end-systolic diameter from the parasternal long-axis view;
LV EDV, LV ESV, and LV EF from the apical four- and two-
chamber views; and LV EDV, LV ESV, LV stroke volume, and LV
EF from the biplane view.Statistical Analysis
All studied parameters were found to satisfy a normal distribution us-
ing the Kolmogorov-Smirnov test, and summary data for these vari-
ables are expressed as mean 6 SD. Multivariate analysis was used
to determine the dependence of the measured parameters on age,
gender, and BSA. Simple univariate linear regression against age
was then used to construct the presented nomograms normalized
for BSA and divided by gender as mean and 95% confidence inter-
vals. P values < .05 were considered significant.
Supplemental Figure 1 For men (left column) and women (right column), the 95% confidence intervals for apical four-chamber view
(top row), apical two-chamber view (middle row) and the biplane (bottom row) LV EDV on the basis of age.
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Supplemental Figure 2 For men (left column) and women (right column), the 95% confidence intervals for apical four-chamber view
(top row), apical two-chamber view (middle row), and the biplane (bottom row) LV ESVs on the basis of age.
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Supplemental Figure 3 For men (left column) and women (right column), the 95% confidence intervals for apical four-chamber view
(top row), apical two-chamber view (middle row), and the biplane (bottom row) LV EDVs on the basis of BSA.
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Supplemental Figure 4 For men (left column) and women (right column), the 95% confidence intervals for apical four-chamber view
(top row), apical two-chamber view (middle row), and the biplane (bottom row) LV ESVs on the basis of BSA.
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Supplemental Table 1 Sources of the data from which LV measurements were obtained, grouped by echocardiographic view,
gender, and baseline characteristics
Parasternal long-axis view Apical four-chamber view Apical two-chamber view Biplane view
Data Sources (n) Asklepios (1,019)
Flemengho (252)
CARDIA5 (1,027)
Asklepios (1,006)
Flemengho (245)
CARDIA25 (588)
Asklepios10 (161)
Flemengho (244)
Padua (111)
Asklepios10 (161)
Flemengho (248)
Men
n 502 962 410 201
Race white (n) 502 770 345 201
Race black (n) 0 192 65 0
Age (y) 45 6 8 37 6 10 50 6 8 47 6 14
Height (cm) 177 6 7 178 6 7 178 6 7 177 6 8
Weight (kg) 78 6 10 77 6 10 80 6 10 79 6 11
BSA (m2) 1.96 6 0.14 1.94 6 0.15 1.99 6 0.15 1.97 6 0.17
BMI (kg/m2) 25 6 3 24 6 3 25 6 3 25 6 3
Women
n 769 1,316 583 319
Race white (n) 769 244 509 319
Race black (n) 0 1,072 74 0
Age (y) 45 6 7 37 6 10 50 6 7 48 6 12
Height (cm) 164 6 6 164 6 6 165 6 6 164 6 7
Weight (kg) 63 6 8 62 6 9 66 6 9 63 6 9
BSA (m2) 1.69 6 0.13 1.68 6 0.13 1.73 6 0.15 1.70 6 0.14
BMI (kg/m2) 23 6 3 23 6 3 24 6 3 24 6 3
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Supplemental Table 2 Normal values for LV size and function parameters for men and women obtained from different
echocardiographic views, listed with the number of subjects used to derive them
Parameter
Male Female
n Mean 6 SD 2-SD range n Mean 6 SD 2-SD range
Parasternal long-axis view*
Diastolic LV internal dimension (mm) 502 50.2 6 4.1 42.0–58.4 769 45.0 6 3.6 37.8–52.2
Systolic LV internal dimension (mm) 389 32.4 6 3.7 25.0–39.8 630 28.2 6 3.3 21.6–34.8
Apical two-chamber view†
LV EF (%) 410 62 6 7 48–76 583 64 6 6 52–76
LV EDV (mL) 410 117 6 29 59–175 583 87 6 23 41–133
LV ESV (mL) 410 45 6 15 15–75 583 32 6 11 10–54
Apical four-chamber view‡
LV EF (%) 962 60 6 7 46–74 1316 62 6 8 46–78
LV EDV (mL) 962 127 6 29 69–185 1316 94 6 23 48–140
LV ESV (mL) 962 50 6 14 22–78 1316 36 6 12 12–60
Biplane§
LV EF (%) 201 62 6 5 52–72 319 64 6 5 54–74
LV EDV (mL) 201 106 6 22 62–150 319 76 6 15 46–106
LV ESV (mL) 201 41 6 10 21–61 319 28 6 7 14–42
Normalized to BSA
Apical two-chamber view†
LV EDV (mL/m2) 410 59 6 14 31–87 583 50 6 12 26–74
LV ESV (mL/m2) 410 23 6 7 9–37 583 18 6 6 6–30
Apical four-chamber view‡
LV EDV (mL/m2) 962 65 6 14 37–93 1316 56 6 13 30–82
LV ESV (mL/m2) 962 26 6 7 12–40 1316 21 6 7 7–35
Biplane§
LV EDV (mL/m2) 201 54 6 10 34–74 319 45 6 8 29–61
LV ESV (mL/m2) 201 21 6 5 11–31 319 16 6 4 8–24
Data Sources.
*Asklepios, Flemengho.
†Asklepios, CARDIA5, Flemengho.
‡Flemengho, CARDIA25; Asklepios10.
§Asklepios10, Flemehgho, Padua.
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Supplemental Table 3 Normal ranges and severity partition cutoff values for 2DE-derived LV size, function and mass
Male Female
Normal
range
Mildly
abnormal
Moderately
abnormal
Severely
abnormal
Normal
range
Mildly
abnormal
Moderately
abnormal
Severely
abnormal
LV dimension
LV diastolic diameter (cm) 4.2–5.8 5.9–6.3 6.4–6.8 >6.8 3.8–5.2 5.3–5.6 5.7–6.1 >6.1
LV diastolic diameter/BSA (cm/m2) 2.2–3.0 3.1–3.3 3.4–3.6 >3.6 2.3–3.1 3.2–3.4 3.5–3.7 >3.7
LV systolic diameter (cm) 2.5–4.0 4.1–4.3 4.4–4.5 >4.5 2.2–3.5 3.6–3.8 3.9–4.1 >4.1
LV systolic diameter/BSA (cm/m2) 1.3–2.1 2.2–2.3 2.4–2.5 >2.5 1.3–2.1 2.2–2.3 2.4–2.6 >2.6
LV volume
LV diastolic volume (mL) 62–150 151–174 175–200 >200 46–106 107–120 121–130 >130
LV diastolic volume/BSA (mL/m2) 34–74 75–89 90–100 >100 29–61 62–70 71–80 >80
LV systolic volume (mL) 21–61 62–73 74–85 >85 14–42 43–55 56–67 >67
LV systolic volume/BSA (mL/m2) 11–31 32–38 39–45 >45 8–24 25–32 33–40 >40
LV function
LV EF (%) 52–72 41–51 30–40 <30 54–74 41–53 30–40 <30
LV mass by linear method
Septal wall thickness (cm) 0.6–1.0 1.1–1.3 1.4–1.6 >1.6 0.6–0.9 1.0–1.2 1.3–1.5 >1.5
Posterior wall thickness (cm) 0.6–1.0 1.1–1.3 1.4–1.6 >1.6 0.6–0.9 1.0–1.2 1.3–1.5 >1.5
LV mass (g) 88–224 225–258 259–292 >292 67–162 163–186 187–210 >210
LV mass/BSA (g/m2) 49–115 116–131 132–148 >148 43–95 96–108 109–121 >121
LV mass by 2D method
LV mass (g) 96–200 201–227 228–254 >254 66–150 151–171 172–193 >193
LV mass/BSA (g/m2) 50–102 103–116 117–130 >130 44–88 89–100 101–112 >112
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Supplemental Table 4 LV function by age decile and gender (mean and 2 SDs)
Parameter
Age 20–29 y Age 30–39 y Age 40–49 y Age 30–59 Age 60
Male Female Male Female Male Female Male Female Male Female
n Mean 6 SD n Mean 6 SD n Mean 6 SD n Mean 6 SD n Mean 6 SD n Mean 6 SD n Mean 6 SD n Mean 6 SD n Mean 6 SD n Mean 6 SD
Apical two-chamber view*
LV EF (%) 14 62 6 4 16 62 6 6 27 62 6 5 18 65 6 5 144 62 6 6 223 63 6 6 191 61 6 8 290 64 6 6 34 63 6 6 36 65 6 6
LV EDV (mL) 14 122 6 18 16 88 6 21 27 111 6 27 18 88 6 14 144 121 6 25 223 90 6 22 191 119 6 30 290 87 6 23 34 88 6 22 36 63 6 12
LV ESV (mL) 14 46 6 7 16 33 6 10 27 42 6 11 18 31 6 7 144 46 6 14 223 34 6 11 191 46 6 16 290 32 6 11 34 32 6 8 36 22 6 6
Apical four-chamber view†
LV EF (%) 247 63 6 6 274 63 6 6 363 61 6 7 478 62 6 8 235 58 6 7 383 60 6 9 96 60 6 7 163 60 6 8 21 59 6 5 18 60 6 6
LV EDV (mL) 247 136 6 29 274 106 6 23 363 131 6 28 478 99 6 23 235 118 6 28 383 84 6 20 96 115 6 29 163 82 6 18 21 110 6 24 18 74 6 15
LV ESV (mL) 247 51 6 13 274 39 6 11 363 51 6 14 478 37 6 11 235 50 6 16 383 34 6 12 96 47 6 16 163 33 6 12 21 45 6 12 18 29 6 7
Biplane‡
LV EF (%) 29 62 6 5 39 63 6 4 34 61 6 4 34 63 6 4 45 62 6 5 82 64 6 4 55 63 6 5 116 64 6 5 38 63 6 5 48 65 6 6
LV EDV (mL) 29 118 6 25 39 87 6 18 34 114 6 22 34 82 6 13 45 107 6 20 82 77 6 13 55 101 6 21 116 73 6 14 38 98 6 21 48 68 6 11
LV ESV (mL) 29 46 6 11 39 32 6 8 34 44 6 10 34 31 6 6 45 41 6 10 82 28 6 6 55 38 6 9 116 26 6 6 38 36 6 9 48 24 6 6
LV stroke volume (mL) 29 73 6 17 39 55 6 12 34 69 6 15 34 52 6 8 45 66 6 12 82 49 6 9 55 64 6 15 116 46 6 10 38 62 6 14 48 44 6 8
Normalized to BSA
Apical two-chamber view*
LV EDV (mL/m2) 14 59 6 8 16 50 6 9 27 56 6 14 18 50 6 8 144 61 6 13 223 52 6 12 191 60 6 14 290 51 6 13 34 45 6 11 36 37 6 7
LV ESV (mL/m2) 14 22 6 4 16 19 6 5 27 21 6 6 18 18 6 4 144 23 6 7 223 19 6 6 191 23 6 8 290 19 6 6 34 16 6 4 36 13 6 3
Apical four-chamber view†
LV EDV (mL/m2) 247 70 6 14 274 63 6 13 363 67 6 13 478 59 6 13 235 60 6 13 383 50 6 11 96 59 6 13 163 49 6 10 21 56 6 11 18 44 6 8
LV ESV (mL/m2) 247 26 6 6 274 23 6 6 363 26 6 7 478 22 6 6 235 26 6 8 383 20 6 7 96 24 6 14 163 20 6 7 21 22 6 5 18 17 6 4
Biplane‡
LV EDV (mL/m2) 29 62 6 10 39 52 6 9 34 57 6 11 34 49 6 6 45 54 6 9 82 45 6 7 55 52 6 9 116 43 6 7 38 50 6 10 48 40 6 7
LV ESV (mL/m2) 29 24 6 5 39 19 6 4 34 22 6 5 34 18 6 4 45 21 6 5 82 16 6 3 55 19 6 4 116 15 6 3 38 18 6 4 48 14 6 3
Data sources.
*Asklepios, CARDIA5, Flemehgho.
†Flemehgho, CARDIA25; Asklepios10.
‡Asklepios10, Flemehgho, Padua.
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Supplemental Table 5 LV size and function by race and gender
Parameter
Black White
Male Female Male Female
n Mean 6 SD n Mean 6 SD n Mean 6 SD n Mean 6 SD
Apical two-chamber view*
LV EF (%) 65 61 6 7 74 64 6 6 345 62 6 7 509 64 6 6
LV EDV (mL) 65 130 6 28 74 99 6 23 345 114 6 28 509 85 6 22
LV ESV (mL) 65 51 6 16 74 36 6 10 345 44 6 14 509 31 6 11
Apical four-chamber view†
LV EF (%) 244 63 6 6 192 64 6 6 770 60 6 7 1072 61 6 8
LV EDV (mL) 244 135 6 29 192 106 6 23 770 125 6 29 1072 91 6 23
LV ESV (mL) 244 50 6 12 192 38 6 11 770 50 6 15 1072 36 6 12
Normalized to BSA
Apical two-chamber view*
LV EDV (mL/m2) 65 66 6 13 74 55 6 11 345 57 6 14 509 50 6 12
LV ESV (mL/m2) 65 26 6 8 74 20 6 6 345 22 6 7 509 18 6 6
Apical four-chamber view†
LV EDV (mL/m2) 244 70 6 14 192 62 6 13 770 64 6 14 1072 54 6 13
LV ESV (mL/m2) 244 26 6 6 192 22 6 6 770 26 6 7 1072 21 6 7
Data sources.
*Asklepios, CARDIA5, Flemengho.
†Flemengho, CARDIA25; Asklepios10.
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Supplemental Table 6 Normal LV strain values from meta-analysis and individual recent publications using specific vendors’
equipment and software
vendor Software n Mean SD LLN
Reference
from list below
Varying Meta-analysis 2597 19.7% NA 1
GE EchoPAC BT 12 247 21.5% 2.0% 18% 2
EchoPAC BT 12 207 21.2% 1.6% 18% 3
EchoPAC BT 12 131 21.2% 2.4% 17% 4
EchoPAC 110.1.3 333 21.3% 2.1% 17% 5
Philips QLAB 7.1 330 18.9% 2.5% 14% 5
Toshiba Ultra Extend 337 19.9% 2.4% 15% 5
Siemens VVI 1.0 116 19.8% 4.6% 11% 6
VVI 1.0 82 17.3% 2.3% 13% 7
Esaote Mylab 50 30 19.5% 3.1% 13% 8
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Supplemental Table 7 Numbers of studies and subjects
used to derive the reference values for RV chamber size and
function
Parameter Studies n
RV basal diameter (mm) 12 695
RV mid-cavity diameter (mm) 14 1938
RVOT PLAX proximal diameter (mm) 11 380
RVOT SAX proximal diameter (mm) 5 193
RVOT SAX distal diameter (mm) 4 159
RV wall thickness (mm) 9 527
RV EDA (cm2)
Men 2 909
Women 2 971
RV EDA indexed to BSA (cm2/m2)
Men 2 909
Women 2 971
RV ESA (cm2)
Men 1 533
Women 1 600
RV ESA indexed to BSA (cm2/m2)
Men 1 533
Women 1 600
RV EDV indexed to BSA (mL/m2)
Men 2 257
Women 2 285
RV ESV indexed to BSA (mL/m2)
Men 2 257
Women 2 285
TAPSE (mm) 68 4803
Pulsed Doppler S wave (cm/s) 69 4752
Color Doppler S wave (cm/s) 9 409
RV fractional area change (%) 57 3606
RV free wall 2D strain (%) 18 782
RV 3D EF (%) 15 1162
Pulsed Doppler MPI 23 853
Tissue Doppler MPI 13 746
E wave deceleration time (ms) 30 1637
E/A 56 2829
e0/a0 33 1230
e0 43 3081
E/e0 8 545
CI, Confidence interval; EDA, end-diastolic area; ESA, end-systolic
area; PLAX, parasternal long-axis view; RVOT, RV outflow tract;
MPI, myocardial performance index.
Values are expressed as mean (95% CI), while normal limit is ex-
pressed as lower reference value (95% CI) and/or *upper reference
value (95% CI) where appropriate.
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Supplemental Table 8 Normal ranges for 3D echocardiographic RV size and function by gender and age decade (from
Maffessanti et al.75)
Age (y) n (women, men)
RV EDV (mL/m2) RV ESV (mL/m2) RV EF (%)
Women Men Women Men Women Men
<30 102 (45, 57) 53 (38, 78) 66 (42, 100) 20 (8, 45) 28 (16, 52) 60 (43, 82) 56 (42, 68)
30–39 96 (50, 46) 50 (38, 77) 58 (35, 85) 18 (11, 38) 23 (12, 38) 63 (50, 78) 60 (47, 74)
40–49 96 (53, 43) 50 (34, 65) 54 (36, 78) 18 (8, 27) 21 (11, 33) 65 (49, 80) 59 (51, 75)
50–59 88 (47, 41) 49 (37, 69) 53 (36, 76) 18 (11, 29) 19 (10, 37) 62 (46, 76) 62 (45, 74)
60–69 69 (39, 30) 46 (26, 64) 52 (37, 86) 17 (8, 26) 19 (10, 36) 61 (50, 79) 63 (49, 79)
$70 37 (23, 14) 43 (25, 62) 54 (31, 68) 12 (7, 21) 18 (7, 28) 71 (57, 82) 65 (55, 76)
Data are expressed as median (5th, 95th percentile).
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Supplemental Table 9 Normal values of LA size
Women Men
AP dimension (cm) 2.7–3.8 3.0–4.0
AP dimension index (cm/m2) 1.5–2.3 1.5–2.3
A4C area index (cm2/m2) 9.3 6 1.7 8.9 6 1.5
A2C area index (cm2/m2) 9.6 6 1.4 9.3 6 1.6
A4C volume index MOD (mL/m2) 25.1 6 7.2 24.5 6 6.4
A4C volume index AL (mL/m2) 27.3 6 7.9 27.0 6 7.0
A2C volume index MOD (mL/m2) 26.1 6 6.7 27.1 6 7.9
A2C volume index AL (mL/m2) 28.0 6 7.3 28.9 6 8.5
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